Influenza and pneumonia

J10_INFLUPNEU

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J09-J18 Cause of death: ICD-10 — J09-J18 2 out of 7 registries used, show all original rules.	77385
4. Check minimum number of events None	77385
5. Include endpoints J10_INFLUENZA J10_VIRALPNEUMO J10_PNEUMOBACT J10_PNEUMONONBACT J10_PNEUMONAS	87692
6. Filter based on genotype QC (FinnGen only)	87692

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	J10_INFLUPNEU
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_INFLUENZA\|J10_VIRALPNEUMO\|J10_PNEUMOBACT\|J10_PNEUMONONBACT\|J10_PNEUMONAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J09\|J1
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J09\|J1
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Influenza and pneumonia based on the number of shared cases.

Similar with more cases:

Diseases of the respiratory system

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1010197	448995	548933
Only index persons	735933	336508	399425
Unadjusted period prevalence (%)
Whole population	14.21	12.86	15.34
Only index persons	13.93	12.37	15.25
Median age at first event (years)
Whole population	64.90	68.38	61.89
Only index persons	59.27	63.59	55.63

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	87692	37714	49978
Unadjusted period prevalence (%)	18.09	12.86	22.03
Median age at first event (years)	62.23	56.87	66.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
36631: Matched controls
279680

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J01FF01

ATC

clindamycin; systemic

1.8

323.0

9345

44501

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

323.0

5232

16066

J01DB01

ATC

cefalexin; oral

1.7

323.0

29298

194739

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

8.9

323.0

811

707

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.7

323.0

7301

23328

I50.9

ICD-10 Finland

Heart failure, unspecified

5.1

323.0

2296

3589

R03BB04

ATC

tiotropium bromide; inhalant

4.4

323.0

3274

6112

R03BA02

ATC

budesonide; inhalant

1.9

323.0

6277

27995

B01AA03

ATC

warfarin; systemic

2.5

323.0

3395

11123

R03DA04

ATC

theophylline; systemic, rectal

4.2

323.0

1471

2787

J01AA02

ATC

doxycycline; systemic

1.7

323.0

26608

169921

J01MA14

ATC

moxifloxacin; systemic

6.5

323.0

5208

7002

J01MA12

ATC

levofloxacin; systemic

3.9

323.0

7867

18498

H02AB07

ATC

prednisone; oral

2.1

323.0

4647

17955

N05AH04

ATC

quetiapine; oral

1.9

323.0

6226

27775

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.7

323.0

1974

3326

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.1

323.0

3074

6123

A46

ICD-10 Finland

Erysipelas

2.4

323.0

3786

12600

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

323.0

4461

15785

A41.9

ICD-10 Finland

Sepsis, unspecified

6.3

323.0

1207

1496

C03CA01

ATC

furosemide; systemic

3.4

323.0

6986

18208

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

40.8

323.0

1676

328

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.7

323.0

2877

4130

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

323.0

19605

111614

C07AB07

ATC

bisoprolol; oral

1.8

323.0

11935

58827

N02BE01

ATC

paracetamol; systemic, rectal

1.8

323.0

29509

196341

N05BA01

ATC

diazepam; systemic, rectal

2.1

323.0

4518

17274

J46

ICD-10 Finland

Status asthmaticus

5.5

323.0

1339

1922

R03AC02

ATC

salbutamol; inhalant

1.9

323.0

20287

109628

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

13427

68358

J12.8

ICD-10 Finland

Other viral pneumonia

482.7

323.0

684

R81

ICPC

Pneumonia

11.1

323.0

1918

1385

A06AD11

ATC

lactulose; oral

2.4

323.0

3439

11468

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

323.0

7448

23830

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

77.6

323.0

1219

124

A28

ICPC

Limited function/disability NOS

3.0

323.0

3198

8674

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

10.4

323.0

1318

1000

N02AA05

ATC

oxycodone; systemic

3.1

323.0

4165

11208

N05CD07

ATC

temazepam; oral

2.4

323.0

3184

10704

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.9

323.0

2900

4865

R03BA05

ATC

fluticasone; inhalant

1.9

323.0

6693

29978

JN4BD

NOMESCO Finland

Extensive body CT

2.7

323.0

3218

9519

48609

ICD-8 Finland

Pneumonia, unspecified

+∞

323.0

1949

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

118.0

323.0

7644

624

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.2

323.0

2368

3661

I50.0

ICD-10 Finland

Congestive heart failure

5.9

323.0

1006

1334

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.1

323.0

2087

5277

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

46.4

323.0

674

113

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

6.9

323.0

978

1115

48509

ICD-8 Finland

Bronchopneumonia, unspecified

+∞

323.0

1344

H02AB06

ATC

prednisolone; systemic

2.2

323.0

17230

80780

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

323.0

9715

44856

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

268.8

323.0

661

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

323.0

3850

12742

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

323.0

5563

22600

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.3

323.0

2042

3088

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

+∞

323.0

2390

47099

ICD-8 Finland

Influenza, unqualified

+∞

323.0

375

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.4

323.0

5619

11158

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

79.7

323.0

474

GD1AD

NOMESCO Finland

Thorax CT examination

4.3

323.0

1465

2660

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

323.0

7467

26325

J18.9

ICD-10 Finland

Pneumonia, unspecified

76.8

323.0

22588

5747

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

323.0

8862

43068

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.1

323.0

4270

8621

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

323.0

4828

16212

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.8

323.0

2442

4092

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.2

323.0

3234

6237

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.9

323.0

3970

6702

ZX120

NOMESCO Finland

Intravenous

2.7

323.0

3360

10062

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

323.0

4927

18728

TGC00

NOMESCO Finland

Bronchial lavation

8.6

323.0

1156

1050

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

323.0

2137

4274

WX892

NOMESCO Finland

Monitored bed care

3.2

323.0

2485

6262

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

8.3

323.0

1414

1343

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.5

323.0

7598

26933

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.7

323.0

3700

11276

R06.0

ICD-10 Finland

Dyspnoea

2.4

323.0

8288

30890

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

323.0

3030

8677

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

323.0

8754

40019

R50.9

ICD-10 Finland

Fever, unspecified

3.2

323.0

6258

17026

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

323.0

17715

57155

R4110

NOMESCO Finland

Physiotherapy

1.8

323.0

8596

39917

AA1AD

NOMESCO Finland

CT of head and brain

2.1

323.0

6584

25889

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.9

323.0

1563

3191

J45.1

ICD-10 Finland

Nonallergic asthma

3.0

323.0

2805

7566

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

280.6

323.0

582

A02BC02

ATC

pantoprazole; systemic

1.7

323.0

21204

125137

N03AX16

ATC

pregabalin; oral

1.8

323.0

7576

34716

J01MA02

ATC

ciprofloxacin; systemic

1.6

323.0

11201

59173

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

323.0

2986

9252

R02

ICPC

Shortness of breath/dyspnoea

2.4

323.0

3988

13432

N05CF01

ATC

zopiclone; oral

1.7

323.0

9453

46622

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.5

323.0

5063

16606

N05AA02

ATC

levomepromazine; systemic

3.6

323.0

1722

3751

J01FA06

ATC

roxithromycin; oral

1.9

323.0

14938

73959

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.3

317.4

1840

4474

WX872

NOMESCO Finland

Intensive care

3.9

317.0

1476

3007

B01AB05

ATC

enoxaparin; parenteral

1.7

315.5

8505

42257

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.4

313.2

3034

10135

A03

ICPC

Fever

1.8

310.6

6540

30076

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

309.9

17374

103874

SPAT1255

SPAT

Intravenous administration of medicine

2.9

309.8

2102

5700

J01CA04

ATC

amoxicillin; systemic

1.7

309.7

29844

202843

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

12.0

309.5

623

403

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

307.0

5941

26546

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.6

306.3

1542

3356

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

305.3

4956

20784

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

301.1

3333

11882

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.9

299.3

1081

1714

R03DC03

ATC

montelukast; oral

1.8

297.5

5960

26914

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

297.1

13328

75408

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

294.1

6776

32003

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

292.7

2061

5721

J96.1

ICD-10 Finland

Chronic respiratory failure

12.5

291.4

575

356

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

287.4

6657

31461

J47

ICD-10 Finland

Bronchiectasis

9.4

286.5

653

541

L28

ICPC

Limited function/disability (L)

2.1

285.1

3723

14275

C08CA01

ATC

amlodipine; oral

1.7

282.4

7819

38937

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

282.2

6235

29010

N05BA04

ATC

oxazepam; oral

1.7

281.4

8046

40428

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

6.3

280.3

826

1022

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.3

278.8

948

1403

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

275.5

3981

15905

R96

ICPC

Asthma

2.3

275.0

2959

10382

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

274.4

7281

35773

N03AG01

ATC

valproic acid; systemic, rectal

2.5

274.4

2379

7466

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

273.7

2155

6400

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

30.6

273.5

401

101

TK800

NOMESCO Finland

Hemodialysis

6.0

270.3

824

1066

R03AC12

ATC

salmeterol; inhalant

3.5

270.3

1441

3279

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

269.8

8169

41621

H02AB04

ATC

methylprednisolone; systemic

1.9

268.3

4671

20015

J15.8

ICD-10 Finland

Other bacterial pneumonia

53.3

267.6

352

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

265.4

2321

7315

127

Kela drug reimbursment

Transplant complication

6.3

263.5

776

959

N05BA06

ATC

lorazepam; systemic, sublingual

3.1

263.5

1612

4062

L04AA06

ATC

mycophenolic acid; systemic

5.5

260.2

849

1196

Z51.5

ICD-10 Finland

Palliative care

3.8

259.2

1236

2565

R05

ICPC

Cough

1.7

259.0

7479

37544

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

255.8

2908

10455

M04AA01

ATC

allopurinol; systemic

2.5

253.4

2219

6992

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

252.1

2249

7159

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

251.9

6034

28668

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

250.3

3176

11991

SPAT1254

SPAT

Administration of medicine

1.9

248.6

4273

18186

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.5

246.7

964

1659

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.2

246.0

1043

1945

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.1

244.1

3087

11631

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

242.2

3228

12434

N06AX11

ATC

mirtazapine; oral

1.5

242.0

10152

55836

J86.9

ICD-10 Finland

Pyothorax without fistula

26.1

241.8

369

109

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

6.0

241.2

733

944

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

240.9

1646

4469

N05AH03

ATC

olanzapine; systemic

2.3

240.1

2413

8165

N06AB04

ATC

citalopram; systemic

1.6

239.6

7022

35281

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

239.4

3889

16194

J45

ICD-10 Finland

Asthma

2.0

238.7

3380

13343

J01DA01

ATC

[U] cefalexin; systemic

1.4

235.7

21081

135455

SPAT1262

SPAT

Handing over of treatment supplies

1.8

235.2

4608

20490

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

235.0

14766

88470

WX882

NOMESCO Finland

High dependency care

4.3

233.1

951

1708

JN4AD

NOMESCO Finland

Body CT examination

2.6

231.0

1912

5830

WX002

NOMESCO Finland

Sedation and analgesia

1.7

230.7

5477

25875

C03DA01

ATC

spironolactone; oral

2.4

229.3

2288

7708

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.9

228.5

1052

2115

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.6

228.5

883

1502

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

227.0

11996

69200

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

24.2

224.2

349

111

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.8

223.5

696

925

J96.0

ICD-10 Finland

Acute respiratory failure

14.6

222.8

411

217

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.8

222.2

1053

2171

N05AH02

ATC

clozapine; systemic

3.9

222.1

1004

1985

T90

ICPC

Diabetes non-insulin dependent

1.7

222.0

5140

24068

S97

ICPC

Chronic ulcer skin

3.2

221.4

1282

3100

R60.0

ICD-10 Finland

Localized oedema

2.1

220.8

2764

10347

XG410

NOMESCO Finland

Flow-volume spirometry

3.1

220.7

1350

3395

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

219.9

1900

5931

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

219.8

2700

10022

A10AE04

ATC

insulin glargine; parenteral

2.2

219.8

2500

8965

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.8

218.1

807

1311

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.5

217.6

1889

5911

48099

ICD-8 Finland

Viral pneumonia

+∞

217.5

232

N05AX08

ATC

risperidone; systemic

2.3

217.4

2245

7687

205

Kela drug reimbursment

Chronic hypertension

1.7

216.0

4988

23321

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

215.6

1569

4429

C09AA05

ATC

ramipril; oral

1.8

215.0

4776

22061

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

214.6

1832

5680

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.3

214.3

2199

7505

R53

ICD-10 Finland

Malaise and fatigue

1.7

213.2

5944

29335

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

213.0

8100

43281

R03AC03

ATC

terbutaline; inhalant

1.7

212.8

4751

21973

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

212.0

6062

30120

R03BA01

ATC

beclometasone; inhalant

1.8

209.2

4382

19855

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

11.9

209.0

421

273

J01FA09

ATC

clarithromycin; systemic

1.5

207.9

11011

63245

J20

ICD-10 Finland

Acute bronchitis

2.0

207.4

3064

12266

4829X

ICD-9 Finland

Other bacterial pneumonia, Bacterial pneumonia unspecified

+∞

206.2

220

J45.8

ICD-10 Finland

Mixed asthma

3.4

206.0

1126

2606

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

12.9

204.5

397

237

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.3

204.4

839

1515

A02BC01

ATC

omeprazole; systemic

1.6

204.3

7641

40600

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

202.6

6490

33179

N03AX12

ATC

gabapentin; oral

1.7

201.3

4572

21225

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.2

201.0

1189

2918

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.3

201.0

679

996

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

200.9

4700

22014

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.4

200.8

1099

2546

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.8

199.8

949

1959

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

198.7

12034

70837

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

198.2

1231

3128

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

198.1

2103

7289

M79.6

ICD-10 Finland

Pain in limb

1.5

197.8

11008

63710

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

9.1

197.7

456

386

S18

ICPC

Laceration/cut

1.4

197.2

11646

68189

R05

ICD-10 Finland

Cough

1.6

197.2

5800

28971

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

197.1

2750

10751

WW500

NOMESCO Finland

Blood transfusion

3.2

196.9

1173

2894

WZC30

NOMESCO Finland

Teaching

1.8

196.4

3778

16622

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

195.8

10739

61939

R11

ICD-10 Finland

Nausea and vomiting

2.1

194.9

2523

9559

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.3

193.7

1098

2610

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.1

192.9

840

1604

SPAT1263

SPAT

Sampling

1.4

192.8

13537

81825

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

192.6

2716

10660

A10BA02

ATC

metformin; oral

1.6

191.0

5966

30243

A04AA01

ATC

ondansetron; systemic, rectal

2.2

190.7

2083

7314

M05BA04

ATC

alendronic acid; oral

2.4

189.5

1797

5884

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

188.9

3170

13288

A07AA02

ATC

nystatin; oral

2.4

188.7

1742

5623

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

188.5

4099

18741

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.3

186.9

1055

2501

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

7.1

186.6

502

546

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.0

186.1

1217

3202

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

185.5

3490

15221

ZXA00

NOMESCO Finland

Right side

1.5

185.4

6952

36830

ZXA05

NOMESCO Finland

Left side

1.6

185.1

6508

33948

G47.3

ICD-10 Finland

Sleep apnoea

1.6

183.9

5939

30326

R95

ICPC

Chron obstructive pulmonary disease

5.4

183.9

610

876

UJF32

NOMESCO Finland

Coloscopy

1.6

183.8

6564

34363

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.2

182.8

2033

7194

4809X

ICD-9 Finland

Viral pneumonia, unspecified

+∞

182.8

195

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

19.3

182.6

304

121

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

182.1

4128

19103

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

+∞

181.8

194

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

181.6

3417

14897

R03AK08

ATC

formoterol and beclometasone; inhalant

2.8

181.6

1328

3752

WX730

NOMESCO Finland

Conventional respirator

5.9

180.0

556

731

XW000

NOMESCO Finland

Bone marrow biopsy

3.2

179.5

1068

2630

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

178.7

13731

84001

C10AA01

ATC

simvastatin; oral

1.5

178.5

8128

44921

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

178.1

190

L04AX01

ATC

azathioprine; systemic

2.5

177.9

1614

5161

B01AC04

ATC

clopidogrel; oral

2.1

176.1

2370

9113

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.6

175.9

680

1156

H02AB02

ATC

dexamethasone; systemic

1.9

175.8

2931

12242

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

6.2

175.5

519

645

130

Kela drug reimbursment

Malignant tumour

2.4

175.3

1693

5590

N05AD01

ATC

haloperidol; systemic

3.6

174.9

879

1902

N03AE01

ATC

clonazepam; systemic

2.3

174.6

1834

6315

N06AA09

ATC

amitriptyline; systemic

1.9

173.3

2857

11879

R03AC13

ATC

formoterol; inhalant

2.5

173.0

1507

4711

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

172.9

5724

29358

B03XA02

ATC

darbepoetin alfa; parenteral

5.6

171.5

549

755

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.9

170.3

523

683

N05AF03

ATC

chlorprothixene; systemic

3.0

170.2

1072

2747

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.4

170.1

902

2037

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

169.3

6561

34920

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.6

169.3

840

1798

J01FA15

ATC

telithromycin; oral

1.8

169.3

3407

15164

N07BB01

ATC

disulfiram; oral

2.4

169.2

1566

5055

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.7

169.0

817

1711

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

168.5

3160

13740

C01DA14

ATC

isosorbide mononitrate; oral

2.4

168.0

1590

5195

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.3

167.7

927

2162

J15.7

ICD-10 Finland

Pneumonia due to Mycoplasma pneumoniae

30.0

167.3

246

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.7

166.8

468

541

48601

ICD-8 Finland

More specifically, unspecified pneumonia and the pleural irritation caused by it

+∞

165.9

177

WX110

NOMESCO Finland

Local anesthesy

1.4

165.7

24202

163961

R03BB01

ATC

ipratropium bromide; inhalant

3.6

164.6

817

1749

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

163.9

1206

3419

SPAT1229

SPAT

Assessment of need for aid

2.3

162.2

1717

5928

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

161.8

1307

3915

N18.8

ICD-10 Finland

Other chronic renal failure

4.7

161.3

601

983

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

161.1

3639

16780

C01AA05

ATC

digoxin; systemic

3.5

160.6

842

1884

M05BX04

ATC

denosumab; parenteral

2.8

159.8

1138

3159

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

159.6

1614

5450

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.8

158.1

580

933

WW200

NOMESCO Finland

Immunization

3.0

157.4

995

2556

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

157.2

1421

4530

WX722

NOMESCO Finland

PEEP

2.7

156.7

1183

3405

AN1

Coronary angiography

2.2

155.7

1718

6045

48298

ICD-8 Finland

Other bacterial pneumonia, Other

+∞

153.7

164

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.4

153.6

840

1942

N04AA02

ATC

biperiden; systemic

3.6

152.5

753

1605

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.7

152.4

1175

3423

49300

ICD-8 Finland

Asthma, bronchiale

3.6

152.4

752

1602

K08.3

ICD-10 Finland

Retained dental root

2.1

151.7

1843

6771

R06.2

ICD-10 Finland

Wheezing

2.4

151.3

1444

4734

207

Kela drug reimbursment

Chronic arrhythmias

2.1

151.2

2000

7620

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.9

151.0

1034

2800

N06AX16

ATC

venlafaxine; oral

1.6

150.4

4893

24896

N03AX09

ATC

lamotrigine; oral

2.1

149.9

1857

6880

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

149.8

2077

8065

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

5.3

149.8

504

736

A11CC03

ATC

alfacalcidol; systemic

4.0

148.5

655

1265

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

6.0

146.2

443

569

XG466

NOMESCO Finland

Sleep oxymetry

3.0

145.8

938

2437

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.5

145.7

564

960

B01AF02

ATC

apixaban; oral

2.3

145.7

1540

5308

Z94.0

ICD-10 Finland

Kidney transplant status

5.4

145.3

478

680

L03AA02

ATC

filgrastim; parenteral

3.2

145.2

830

1984

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

145.1

2020

7852

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.5

144.7

751

1667

R04.2

ICD-10 Finland

Haemoptysis

3.6

144.2

728

1580

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.9

143.6

515

809

A02BC05

ATC

esomeprazole; systemic

1.4

143.3

11843

72533

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

143.1

1445

4870

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

142.3

3155

14433

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

141.8

1560

5479

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.9

141.5

949

2535

R06AE07

ATC

cetirizine; oral

1.3

141.1

15088

96171

201

Kela drug reimbursment

Chronic cardiac insufficiency

3.5

140.7

740

1660

H02AB09

ATC

hydrocortisone; systemic

3.1

139.5

846

2110

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

139.3

1373

4570

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

139.2

1906

7358

R51.80

ICD-10 Finland

Headache

1.5

137.3

5002

26094

R05FB02

ATC

cough suppressants and expectorants

1.4

136.6

10495

63373

ZX108

NOMESCO Finland

Inhalation

8.3

136.6

331

306

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.9

136.3

421

554

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.3

136.3

554

991

L17

ICPC

Foot/toe symptom/complaint

1.4

135.7

7055

39695

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

135.5

7239

40945

N06AB03

ATC

fluoxetine; oral

1.6

135.2

4019

19942

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

42.8

135.1

184

J10.8

ICD-10 Finland

Influenza with other manifestations, seasonal influenza virus identified

84.9

134.9

166

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.5

134.8

703

1566

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

4.0

131.6

580

1120

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

2.9

131.1

879

2346

N30.0

ICD-10 Finland

Acute cystitis

1.6

130.7

3932

19556

ZXA10

NOMESCO Finland

Bilateral

1.5

130.0

4652

24139

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

130.0

9709

58244

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

129.3

2678

11977

I50.1

ICD-10 Finland

Left ventricular failure

3.7

129.0

627

1319

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

128.6

1742

6690

C10AA05

ATC

atorvastatin; oral

1.4

128.5

7661

44164

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

4.5

126.8

491

837

E87.6

ICD-10 Finland

Hypokalaemia

3.0

125.9

809

2100

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.2

125.6

724

1741

P01AB01

ATC

metronidazole; oral, rectal

1.3

125.6

12618

79213

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

125.1

4973

26409

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

125.0

1190

3892

48199

ICD-8 Finland

Pneumococcal pneumonia

+∞

124.6

133

SPAT1216

SPAT

Assessment of functional ability

1.7

124.5

3037

14259

A12AA04

ATC

calcium carbonate; oral

4.8

123.9

456

737

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.5

123.8

319

326

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

123.6

7996

46715

M10.9

ICD-10 Finland

Gout, unspecified

2.6

123.6

987

2934

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.0

123.0

538

1032

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

11.4

122.7

251

169

N05AB03

ATC

perphenazine; systemic, rectal

2.4

122.5

1165

3807

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.9

122.2

333

370

J18

ICD-10 Finland

Pneumonia, organism unspecified

7.9

121.9

304

295

V03AE01

ATC

polystyrene sulfonate; oral

7.0

121.9

331

366

A02BC03

ATC

lansoprazole; oral

1.4

121.7

7669

44582

EBA00

NOMESCO Finland

Extraction of tooth

1.3

121.4

10422

63784

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

121.1

2710

12402

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

121.1

2157

9172

R33

ICD-10 Finland

Retention of urine

2.6

121.1

1002

3038

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.0

121.0

786

2055

Z71.8

ICD-10 Finland

Other specified counselling

1.4

120.6

7612

44249

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

120.0

638

1443

L04AD01

ATC

ciclosporin; systemic

3.2

119.2

692

1672

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

119.0

2408

10680

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

3.0

118.7

741

1885

C09AA02

ATC

enalapril; systemic

1.6

118.3

3607

17970

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.8

118.2

368

490

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

118.1

1570

5980

N03AF01

ATC

carbamazepine; oral, rectal

2.2

118.0

1339

4762

A12BA01

ATC

potassium chloride; oral

3.4

117.6

631

1438

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.2

117.2

345

427

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

116.7

4794

25601

W19

ICD-10 Finland

Unspecified fall

1.8

116.6

2444

10956

N05AX12

ATC

aripiprazole; systemic

2.1

116.1

1502

5656

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

116.0

3173

15361

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.4

115.9

332

396

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

115.5

1391

5080

137

Kela drug reimbursment

Uraemia requiring dialysis

6.4

115.3

331

396

M54.5

ICD-10 Finland

Low back pain

1.3

115.3

10167

62358

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

115.0

1302

4627

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.2

114.2

387

571

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

6.7

114.0

316

360

N05BA02

ATC

chlordiazepoxide; systemic

3.1

113.7

681

1683

C07AB02

ATC

metoprolol; systemic

1.6

113.7

3745

19005

E86

ICD-10 Finland

Volume depletion

4.3

113.6

462

827

4878X

ICD-9 Finland

Influenza, With other manifestations

+∞

113.4

121

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

113.1

1639

6458

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

113.0

2420

10918

A02BA02

ATC

ranitidine; systemic

1.5

112.8

4627

24686

J01FA10

ATC

azithromycin; systemic

1.3

112.7

20997

142743

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

112.7

4399

23215

N05AA01

ATC

chlorpromazine; systemic, rectal

3.8

112.5

526

1071

N06AA12

ATC

doxepin; systemic

2.1

112.3

1362

4990

N19

ICD-10 Finland

Unspecified kidney failure

3.9

112.3

512

1020

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.6

112.2

918

2765

R42

ICD-10 Finland

Dizziness and giddiness

1.5

111.9

5081

27690

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

111.8

1707

6860

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.7

111.8

834

2381

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

111.6

2060

8860

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

111.4

585

1311

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.3

111.4

323

392

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.8

110.6

520

1064

A04

ICPC

Weakness/tiredness general

1.6

110.5

3500

17584

R03AK11

ATC

formoterol and fluticasone; inhalant

2.7

110.2

810

2291

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.9

110.2

731

1936

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

109.8

1156

3971

B01AB10

ATC

tinzaparin; parenteral

1.9

109.7

1706

6905

UKC02

NOMESCO Finland

Cystoscopy

1.7

109.7

2675

12537

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

109.5

2127

9301

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

109.0

1603

6352

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

108.8

2454

11243

SPAT1234

SPAT

Support of social functional capacity

2.4

108.2

1027

3351

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

107.8

2895

13935

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

107.2

10221

63268

R4190

NOMESCO Finland

Nutritional therapy

2.3

107.1

1107

3769

E66.8

ICD-10 Finland

Other obesity

1.9

107.0

1784

7404

N06AX21

ATC

duloxetine; oral

1.6

106.9

3322

16603

GBB00

NOMESCO Finland

Tracheostomy

6.1

106.8

317

397

4810A

ICD-9 Finland

Pneumococcal pneumonia[PNEUMONIA PNEUMOCOCCICA]

+∞

106.8

114

A10AE05

ATC

insulin detemir; parenteral

2.0

106.3

1439

5518

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

106.1

9037

54980

SPAT1260

SPAT

Consultation of another employee

1.5

106.1

4822

26252

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

106.0

3220

15999

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.9

105.8

484

967

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.5

105.8

412

707

P72

ICPC

Schizophrenia

3.0

105.2

676

1755

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

105.1

2435

11236

J94.8

ICD-10 Finland

Other specified pleural conditions

5.6

104.3

333

458

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

104.3

689

1822

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.7

103.7

389

642

N05AN01

ATC

lithium; oral

2.5

103.6

887

2740

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

103.6

3113

15417

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

103.5

1842

7819

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

103.5

1818

7683

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

103.0

5201

52322

A41.8

ICD-10 Finland

Other specified sepsis

5.0

102.5

359

550

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.2

102.4

592

1427

SPAT1301

SPAT

No procedures

1.3

102.2

8594

52124

R03BA08

ATC

ciclesonide; inhalant

1.7

102.1

2446

11396

A04AA02

ATC

granisetron; systemic, transdermal

1.9

101.7

1586

6422

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

101.4

922

2941

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

101.2

11358

71816

N18.0

ICD-10 Finland

End-stage renal disease

5.8

101.2

315

420

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

100.6

1358

5200

P15

ICPC

Chronic alcohol abuse

2.5

100.5

880

2752

S06.0

ICD-10 Finland

Concussion

1.6

100.2

2919

14338

A01AB09

ATC

miconazole; local oral

1.7

100.2

2287

10502

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

99.8

813

2443

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

99.8

1265

4719

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

99.7

2478

11665

A01

ICPC

Pain general/multiple sites

1.8

99.5

2008

8881

4871A

ICD-9 Finland

Influenza, With other respiratory manifestations

+∞

99.3

106

48399

ICD-8 Finland

Pneumonia due to other specified organism

+∞

99.3

106

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.9

99.2

445

874

R4120

NOMESCO Finland

Occupational therapy

1.9

99.1

1726

7269

E87.5

ICD-10 Finland

Hyperkalaemia

5.8

98.3

303

399

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

98.0

2348

10933

B03XA01

ATC

erythropoietin; parenteral

7.8

98.0

246

242

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

97.7

1432

5663

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.1

97.6

291

367

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

97.5

1877

8177

A08

ICPC

Swelling

2.4

97.0

923

3015

I50

ICD-10 Finland

Heart failure

5.1

96.4

333

503

L04AA01

ATC

[U] ciclosporin; systemic

3.4

96.3

504

1127

N06AX03

ATC

mianserin; oral

2.0

96.2

1269

4814

K78

ICPC

Atrial fibrillation/flutter

2.4

95.4

901

2933

N05AC02

ATC

thioridazine; oral

2.8

95.3

675

1867

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

95.1

1629

6821

R55

ICD-10 Finland

Syncope and collapse

1.7

95.0

2163

9920

A10BH01

ATC

sitagliptin; oral

1.8

94.8

1757

7553

N06AB06

ATC

sertraline; oral

1.5

94.7

3556

18552

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

94.6

2106

9596

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

8.1

94.5

232

220

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.0

94.0

253

277

N05AF05

ATC

zuclopenthixol; systemic

4.1

93.9

399

746

R41.0

ICD-10 Finland

Disorientation, unspecified

3.4

93.8

497

1122

RS221

NOMESCO Finland

3.3

93.8

515

1195

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.6

93.6

354

590

NHQ40

NOMESCO Finland

Amputation of toe

5.3

93.5

314

459

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

93.3

2996

15066

E0000UV

ATC

1.3

93.0

12178

78351

C02AC05

ATC

moxonidine; oral

2.4

93.0

840

2672

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.5

92.4

785

2415

A29

ICPC

General symptom/complaint other

1.6

92.3

2643

12915

J43.9

ICD-10 Finland

Emphysema, unspecified

6.0

92.2

278

356

A07AA09

ATC

vancomycin; oral

4.4

91.8

360

623

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.6

91.7

258

301

S22.3

ICD-10 Finland

Fracture of rib

1.9

91.1

1443

5872

4830A

ICD-9 Finland

Pneumonia due to other specified organism, Mycoplasma pneumoniae[PNEUMONIA E MYCOPLASMA PNEUMONIAE]

+∞

90.9

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

90.8

5696

32842

N03AX14

ATC

levetiracetam; systemic

2.6

90.7

726

2161

RS220

NOMESCO Finland

3.5

90.4

471

1050

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

1.9

90.4

1464

6005

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.8

90.3

329

527

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

90.3

2117

9789

SPAT1104

SPAT

Monitoring of emergency patient

1.8

90.3

1575

6634

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

90.0

1155

4329

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.4

90.0

475

1070

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.1

89.8

547

1370

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.2

89.7

520

1257

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

89.6

1644

7043

N17.8

ICD-10 Finland

Other acute renal failure

6.0

89.6

270

346

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

89.5

1251

4855

WF004

NOMESCO Finland

Palliative radiotherapy

4.0

89.4

388

740

X58

ICD-10 Finland

Exposure to other specified factors

1.5

89.4

4118

22413

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

88.7

2255

10669

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

4.7

88.2

329

541

B05DA

ATC

Isotonic solutions

6.2

88.1

260

324

XF404

NOMESCO Finland

Ambulatory ECG

1.7

87.9

1973

9006

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

87.9

2274

10810

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

87.5

2334

11185

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

87.4

2758

13799

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

87.4

2928

14864

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

87.2

973

3431

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.0

86.9

554

1430

C08CA13

ATC

lercanidipine; oral

1.6

86.9

2422

11743

F10.24

ICD-10 Finland

Alcohol depence active use

3.3

86.8

488

1153

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

86.7

4862

27459

ZX112

NOMESCO Finland

Subcutaneous

2.9

86.6

572

1512

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.9

86.4

308

482

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.8

86.3

1682

7349

A10BB12

ATC

glimepiride; oral

2.3

86.1

902

3088

Z49.2

ICD-10 Finland

Other dialysis

6.2

85.6

252

313

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

85.6

1087

4056

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

2.8

85.3

606

1679

WX402

NOMESCO Finland

General anaesthesia

1.4

85.0

4811

27207

WX704

NOMESCO Finland

Intubation

1.7

84.9

1938

8888

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

84.9

3432

18170

F05.9

ICD-10 Finland

Delirium, unspecified

4.2

84.6

351

642

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.6

84.4

656

1919

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.2

84.3

894

3079

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

83.9

3399

17997

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

83.3

2243

10770

S29

ICPC

Skin symptom/complaint other

1.4

83.2

4250

23577

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

12.4

83.1

163

101

C08CA02

ATC

felodipine; oral

1.9

83.1

1433

6008

TK810

NOMESCO Finland

Hemofiltration

7.0

82.8

222

242

G04CA02

ATC

tamsulosin; oral

1.7

82.8

1960

9083

C09CA01

ATC

losartan; oral

1.4

82.6

4964

28358

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

82.6

2591

12939

SPAT1325

SPAT

Vaccination

1.3

82.3

8337

51640

49099

ICD-8 Finland

Bronchitis, unspecified

4.1

82.2

348

649

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.6

82.2

672

2023

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

82.0

1046

3910

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.8

81.9

562

1523

R07.3

ICD-10 Finland

Other chest pain

1.6

81.9

2233

10760

N05BE01

ATC

buspirone; oral

2.3

81.8

861

2954

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

81.4

2486

12330

V03AA01

ATC

3.3

81.2

449

1049

SPAT1252

SPAT

Overall medication plan or its review

1.9

81.1

1316

5402

A10BH05

ATC

linagliptin; oral

2.5

81.0

688

2117

V03AE02

ATC

sevelamer; oral

7.8

80.9

203

200

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.2

80.9

337

619

EBA30

NOMESCO Finland

Excision of root of tooth

1.9

80.9

1218

4860

D07AC01

ATC

betamethasone; topical

1.3

80.8

9317

58698

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.7

80.7

385

799

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

80.6

1425

6027

SPAT1097

SPAT

Recording of ECG

1.5

80.4

3053

15930

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.5

80.3

228

270

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.1

80.2

484

1203

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.6

80.2

2620

13209

J01DA06

ATC

[U] cefuroxime; systemic

1.4

79.8

4221

23550

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

79.8

7304

44567

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

79.8

2464

12253

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

9.3

79.8

180

148

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

79.7

1903

8840

H3603, E103

ICD-10 Finland

3.5

79.6

414

922

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

79.5

1810

8293

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.1

79.5

932

3359

K92.0

ICD-10 Finland

Haematemesis

3.0

79.3

512

1335

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.7

79.2

579

1634

N05BA12

ATC

alprazolam; oral

1.5

79.1

2813

14463

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.4

78.8

419

950

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.0

78.8

346

668

K07

ICPC

Swollen ankles/oedema

2.4

78.8

741

2407

5AH02

NOMESCO Finland

140.8

78.6

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.0

78.5

1067

4093

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

78.5

1046

3982

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.0

78.3

495

1271

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.8

78.1

563

1574

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

77.9

8502

53122

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

77.8

2275

11155

G72.8

ICD-10 Finland

Other specified myopathies

4.3

77.8

314

560

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.8

77.5

1378

5839

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.7

77.4

585

1683

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.5

77.3

674

2104

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

77.2

725

2353

ZZA00

NOMESCO Finland

Split skin graft

2.7

77.0

586

1692

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

77.0

1507

6588

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.4

76.6

707

2274

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

76.5

1116

4402

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.0

76.4

269

416

R13

ICD-10 Finland

Dysphagia

1.8

76.4

1383

5894

K92.1

ICD-10 Finland

Melaena

2.2

76.3

872

3109

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

76.2

2602

13248

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

4.9

76.2

272

427

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

76.2

936

3443

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.3

76.1

800

2744

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

75.8

1297

5422

S72.0

ICD-10 Finland

Fracture of neck of femur

3.3

75.8

424

998

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

75.7

740

2451

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

75.7

18181

124456

N03AF02

ATC

oxcarbazepine; oral

2.1

75.6

895

3240

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.2

75.0

425

1012

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

74.9

473

1215

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

74.9

1649

7477

J01EA01

ATC

trimethoprim; systemic

1.3

74.5

6876

41944

C90.0

ICD-10 Finland

Multiple myeloma

5.6

74.3

236

324

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

74.3

2977

15704

R01AD08

ATC

fluticasone; nasal

1.3

73.9

8935

56496

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.6

73.9

588

1745

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.8

73.7

202

228

196

Kela drug reimbursment

Paricalcitol and cinacalcet

8.2

73.6

179

168

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.6

73.6

586

1739

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.5

73.2

281

477

T89

ICPC

Diabetes insulin dependent

1.9

73.1

1167

4759

M48.0

ICD-10 Finland

Spinal stenosis

1.6

73.1

2067

10043

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

72.9

1974

9482

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.7

72.7

228

308

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.6

72.5

273

454

P01BA02

ATC

hydroxychloroquine; oral

1.6

72.5

2253

11209

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.8

72.4

332

667

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

72.2

5888

35252

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

71.6

1183

4886

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

71.4

3100

16619

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.8

71.3

508

1411

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

71.0

3613

19981

I20.09

ICD-10 Finland

Unstable angina

2.3

71.0

726

2457

A10AA02

ATC

2.1

70.9

847

3079

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

70.8

1317

5662

I25.2

ICD-10 Finland

Old myocardial infarction

2.5

70.5

605

1872

K02.1

ICD-10 Finland

Caries of dentine

1.2

70.4

19587

135666

L04AX04

ATC

lenalidomide; oral

10.1

69.9

151

115

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

14.1

69.7

129

S01.0

ICD-10 Finland

Open wound of scalp

1.7

69.7

1519

6864

Z94.2

ICD-10 Finland

Lung transplant status

20.1

69.4

113

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.8

69.4

496

1381

L01CA04

ATC

vinorelbine; systemic

5.5

69.2

224

315

N07BA03

ATC

varenicline; oral

1.7

69.2

1575

7207

SPAT1167

SPAT

Insertion of urinary catheter

3.3

69.2

385

905

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

69.1

15996

108624

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.0

69.1

242

373

153

Kela drug reimbursment

Lenalidomid

9.0

69.0

158

134

B01AB04

ATC

dalteparin; parenteral

1.9

68.9

1038

4144

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

68.9

8099

50942

XKD00

NOMESCO Finland

Uroflowmetry

1.7

68.9

1725

8114

120

Kela drug reimbursment

Hypogammaglobulinaemia

12.5

68.9

134

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

68.8

954

3687

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

68.5

647

2106

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

68.3

1431

6389

R74

ICPC

Upper respiratory infection acute

1.2

68.3

10139

65587

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.0

68.2

297

570

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

68.1

574

1759

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.1

68.0

416

1046

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

67.9

2675

14046

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

7.8

67.8

170

168

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

67.6

545

1629

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.0

67.6

181

198

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

67.5

1860

8974

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.0

67.4

962

3763

R52.9

ICD-10 Finland

Pain, unspecified

1.6

67.3

2167

10870

R29

ICPC

Respiratory symptom/complaint other

1.6

67.2

1700

8016

B05DB

ATC

Hypertonic solutions

5.8

67.2

207

274

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.8

67.1

4635

44983

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.5

67.1

341

747

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.5

67.0

590

1852

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

67.0

11728

77242

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

66.9

1532

7023

JAH00

NOMESCO Finland

Laparotomy

2.4

66.8

608

1941

S76

ICPC

Skin infection other

1.8

66.7

1168

4919

XG460

NOMESCO Finland

Short time oxymetry

3.6

66.7

327

696

U04

ICPC

Incontinence urine

2.1

66.4

834

3097

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.6

66.3

518

1522

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

66.3

776

2795

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

66.2

1017

4089

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.0

66.1

426

1110

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.9

65.9

296

584

F61.0

ICD-10 Finland

Mixed personality disorders

2.4

65.9

622

2025

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.4

65.8

587

1854

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.5

65.8

573

1789

A99

ICPC

Disease/condition unspecnature/site

1.6

65.8

1839

8907

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.5

65.7

580

1822

M25.5

ICD-10 Finland

Pain in joint

1.3

65.6

8499

54037

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

65.6

3256

17906

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

65.6

603

1935

Z72.0

ICD-10 Finland

Tobacco use

2.2

65.6

736

2603

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.5

65.5

549

1679

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.3

65.4

189

230

XF402

NOMESCO Finland

ECG with work load test

1.5

65.3

2143

10795

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

4.5

65.3

252

431

UJD02

NOMESCO Finland

Gastroscopy

1.9

65.3

1043

4255

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.3

65.2

261

463

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.7

64.9

473

1333

R01AD09

ATC

mometasone; nasal

1.2

64.9

14744

99695

C03AA03

ATC

hydrochlorothiazide; oral

1.6

64.8

1640

7732

SPAT1324

SPAT

Screening procedure

0.7

64.8

4119

40443

P99

ICPC

Psychological disorders other

2.0

64.6

909

3535

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

64.5

913

3559

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

64.4

703

2454

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

64.3

1765

8504

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.5

64.2

326

714

S10

ICPC

Boil/carbuncle

1.7

64.0

1371

6162

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

63.8

1554

7249

K59.0

ICD-10 Finland

Constipation

1.8

63.8

1144

4856

ZX100

NOMESCO Finland

Oral

3.3

63.7

344

791

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.5

63.7

322

703

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

63.6

12179

80855

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

63.6

970

3891

N06AB10

ATC

escitalopram; oral

1.3

63.4

6486

39997

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

63.3

783

2890

K65.0

ICD-10 Finland

Acute peritonitis

4.1

63.3

270

509

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.3

63.2

341

784

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

63.1

1129

4791

L03AA13

ATC

pegfilgrastim; parenteral

1.9

63.0

989

4009

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.7

62.9

476

1372

J01DC02

ATC

cefuroxime; systemic

1.6

62.3

1675

8026

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.9

62.2

408

1077

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

42.8

62.1

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.0

62.0

267

508

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

62.0

1056

4407

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.2

61.9

654

2250

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.4

61.8

583

1897

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

61.5

3015

16532

L03

ICPC

Low back symptom/complaint

1.3

61.4

6804

42367

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

61.2

23573

167395

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

61.1

4519

26585

4828X

ICD-9 Finland

Other bacterial pneumonia, Pneumonia due to other specified bacteria

+∞

60.9

C01BD01

ATC

amiodarone; systemic

2.8

60.9

426

1172

R31

ICD-10 Finland

Unspecified haematuria

1.7

60.7

1379

6302

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

60.6

688

2445

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

3.0

60.5

377

960

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.2

60.4

177

220

A10AA01

ATC

2.0

60.4

787

2968

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.6

60.3

298

639

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.8

60.1

428

1188

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.5

60.0

230

391

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.0

59.8

178

226

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

59.7

5367

32480

N06AB05

ATC

paroxetine; oral

1.6

59.7

1809

8934

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

59.7

1295

5840

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

59.7

1538

7285

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

11.5

59.4

120

W78

ICPC

Pregnancy

0.7

59.3

2718

28020

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.9

59.1

262

512

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.2

59.1

243

443

OAB43

SPAT

0.8

59.1

4109

39920

TGA30

NOMESCO Finland

Thoracocentesis

8.0

59.1

145

139

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.5

59.0

504

1558

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

3.3

58.9

324

756

RD210

NOMESCO Finland

2.3

58.7

566

1864

N05AB01

ATC

dixyrazine; systemic

3.3

58.7

318

734

R04.0

ICD-10 Finland

Epistaxis

1.8

58.6

1187

5242

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

58.6

773

2931

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.6

58.5

285

604

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

58.5

2246

11715

RS222

NOMESCO Finland

3.2

58.3

332

795

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.4

58.3

306

689

SPAT1059

SPAT

Spirometry at the office

1.8

58.3

1169

5147

Z00.0

ICD-10 Finland

General medical examination

1.3

58.3

4836

28926

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

58.2

518

1637

J96.9

ICD-10 Finland

Respiratory failure, unspecified

7.3

58.2

151

158

3AC01

NOMESCO Finland

3.4

58.2

304

682

J01CF05

ATC

flucloxacillin; systemic

1.9

58.2

914

3705

SPAT1211

SPAT

Application of soft bandage

1.5

57.7

2202

11471

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

9.5

57.7

128

103

SPAT1197

SPAT

Extensive health check-up of expecting family

0.7

57.7

2373

24897

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.1

57.6

342

844

SPAT1053

SPAT

Memory test

1.6

57.6

1527

7289

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.8

57.5

390

1052

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.8

57.5

392

1059

XQ800

NOMESCO Finland

Prick test

1.5

57.2

2412

12831

4808X

ICD-9 Finland

Viral pneumonia, Pneumonia due to other virus not elsewhere classified

+∞

57.1

SPAT1310

SPAT

Counselling related to known health issue

1.2

57.1

9024

58522

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.2

57.1

235

429

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.8

57.0

207

333

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

22.7

56.8

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.8

56.7

394

1080

C07AG02

ATC

carvedilol; oral

1.9

56.7

900

3664

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.4

56.5

292

650

R03DC01

ATC

zafirlukast; oral

2.7

56.4

410

1154

N05CF02

ATC

zolpidem; oral

1.3

56.4

4968

29955

WYA20

NOMESCO Finland

Home visit

4.0

56.3

246

475

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.3

56.3

555

1848

-50

ICPC

Medication/prescr/renewal

1.9

56.1

926

3821

H05BX01

ATC

cinacalcet; oral

6.3

56.1

161

195

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

55.9

6393

39903

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.1

55.9

330

811

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

7.6

55.9

142

144

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

55.9

542

1790

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.8

55.7

1015

4333

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

55.6

1735

8628

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

55.5

537

1771

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

55.5

1464

6976

C08DB01

ATC

diltiazem; oral

2.2

55.5

598

2075

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.2

55.4

311

736

X57

ICD-10 Finland

Unspecified privation

2.3

55.4

559

1881

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.4

55.0

290

656

B02.9

ICD-10 Finland

Zoster without complication

1.7

54.9

1127

4995

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

54.9

1752

8760

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

54.9

902

3717

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

54.7

659

2404

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.9

54.6

243

477

WVA20

NOMESCO Finland

Medicine administration

2.4

54.6

519

1697

N05AD03

ATC

melperone; systemic

3.6

54.5

268

573

N02AA01

ATC

morphine; systemic, rectal

5.5

54.5

174

242

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

54.4

964

4077

J02AC03

ATC

voriconazole; systemic

13.8

54.3

101

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

54.2

533

1771

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.8

54.2

252

514

GDG10

NOMESCO Finland

Bilateral transplantation of lung

23.0

53.9

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

53.8

1408

6692

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

53.8

959

4062

N05CD02

ATC

nitrazepam; oral

3.1

53.8

314

766

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.0

53.7

334

852

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.7

53.6

166

222

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

2.5

53.6

448

1369

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

53.6

1307

6098

WZA90

NOMESCO Finland

Other doctors statement

1.3

53.6

6916

43775

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

450.2

53.5

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.1

53.5

321

798

J15.0

ICD-10 Finland

Pneumonia due to Klebsiella pneumoniae

+∞

53.4

A01AB04

ATC

amphotericin B; local oral

1.8

53.2

974

4164

M05BA07

ATC

risedronic acid; oral

2.2

53.2

557

1909

SPAT1251

SPAT

Organisation of medication

2.0

53.2

704

2674

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.6

53.1

409

1193

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

5.2

53.1

178

262

TJD20

NOMESCO Finland

Change of gastrostomy tube

8.1

53.1

129

122

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.7

53.1

384

1080

H03AA01

ATC

levothyroxine sodium; systemic

1.3

53.0

6386

40080

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.3

53.0

287

663

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.2

52.9

217

395

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.7

52.9

248

510

M02AA07

ATC

piroxicam; topical

1.2

52.9

8974

58546

P20

ICPC

Memory disturbance

1.7

52.9

1230

5660

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

52.8

668

2491

WW300

NOMESCO Finland

Transfer of autologic stem cells

6.1

52.7

155

194

P29

ICPC

Psychological sympt/compl other

1.5

52.6

1859

9513

R52.2

ICD-10 Finland

Other chronic pain

1.9

52.6

844

3448

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.9

52.5

159

207

S20.2

ICD-10 Finland

Contusion of thorax

1.7

52.3

1106

4948

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.5

52.3

268

593

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

52.1

988

4271

XG405

NOMESCO Finland

Education on PEF monitoring

2.6

52.1

398

1155

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.2

52.0

544

1863

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.1

52.0

629

2301

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

5.8

51.9

160

213

H25.8

ICD-10 Finland

Other senile cataract

1.7

51.9

1157

5259

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3.0

51.9

323

824

J05AB11

ATC

valaciclovir; oral

1.4

51.8

3419

19722

J80

ICD-10 Finland

Adult respiratory distress syndrome

13.2

51.7

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

51.6

670

2524

TK820

NOMESCO Finland

Peritoneal dialysis

5.9

51.6

155

200

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

51.4

2846

15934

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

51.2

7643

49143

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.4

51.1

271

616

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

51.1

382

1095

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

6.3

51.1

147

179

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

51.1

1712

8655

H26.3

ICD-10 Finland

Drug-induced cataract

4.4

51.1

201

352

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

51.0

1459

7096

N05AL01

ATC

sulpiride; systemic

2.6

51.0

396

1161

D07AB08

ATC

desonide; topical

1.4

51.0

2740

15255

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.8

51.0

932

3983

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

50.9

753

2984

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

50.9

479

1559

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.0

50.9

669

2532

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

50.9

1526

7514

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

50.8

997

4360

Angiography of the heart and coronary arteries

2.3

50.7

522

1774

E000001

ATC

1.3

50.7

5856

36539

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

1.8

50.6

881

3702

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.9

50.6

325

846

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.5

50.5

423

1295

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.0

50.4

321

832

R78

ICPC

Acute bronchitis/bronchiolitis

2.2

50.4

552

1931

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.1

50.4

643

2406

SPAT1153

SPAT

Removal of sutures

1.2

50.4

7570

48698

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.4

50.3

458

1466

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.1

50.3

170

253

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.2

50.3

530

1823

348

Kela drug reimbursment

Roflumilast

19.6

50.2

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

50.2

4132

24642

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

50.1

1385

6679

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

50.1

12719

86203

WX320

NOMESCO Finland

Spinalanesthesy

1.3

50.1

5256

32398

5CM18

NOMESCO Finland

8.9

50.1

115

R10.0

ICD-10 Finland

Acute abdomen

1.9

50.1

800

3265

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.6

50.0

187

311

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.3

50.0

485

1602

J01FA01

ATC

erythromycin; systemic

1.3

49.9

4520

27316

TAB00

NOMESCO Finland

Lumbar puncture

1.7

49.7

1201

5587

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

49.7

9029

59242

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

49.5

1801

9275

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

49.5

11591

77950

V03AE03

ATC

lanthanum carbonate; oral

7.1

49.5

131

142

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.9

49.4

320

840

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

49.3

1696

8625

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.0

49.3

212

404

Z50.1

ICD-10 Finland

Other physical therapy

1.7

49.3

1203

5612

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.5

49.3

411

1255

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

49.2

1004

4443

I95.1

ICD-10 Finland

Orthostatic hypotension

2.7

49.2

363

1033

NF3AA

NOMESCO Finland

Femur X-ray examination

2.7

49.2

366

1046

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.2

48.9

533

1862

29599

ICD-8 Finland

Schizophrenia, Unspecified type

5.2

48.9

164

242

M01AX17

ATC

nimesulide; oral

1.3

48.9

5588

34804

K77

ICPC

Heart failure

4.3

48.6

195

348

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.8

48.6

346

964

F20.10

ICD-10 Finland

Raise schizophrenia continuously

4.8

48.6

176

283

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.6

48.5

377

1106

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

48.5

821

3419

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.3

48.5

496

1681

J98.1

ICD-10 Finland

Pulmonary collapse

6.3

48.4

139

169

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.9

48.4

314

825

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

48.4

1658

8427

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.6

48.3

236

503

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

48.2

2695

15107

N02AC04

ATC

dextropropoxyphene; oral

2.1

48.2

568

2056

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

6.3

48.0

138

168

S21

ICPC

Skin texture symptom/complaint

1.4

48.0

2840

16076

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

4.6

47.9

178

294

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.7

47.9

149

201

SPAT1058

SPAT

PEF monitoring instruction

1.5

47.9

1947

10269

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

47.8

1015

4547

1240

FHL

Bronchoscopy

4.4

47.8

187

326

Z29.0

ICD-10 Finland

Isolation

7.0

47.7

127

139

A10BB01

ATC

glibenclamide; oral

3.1

47.7

278

679

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

47.6

480

1616

C07AA05

ATC

propranolol; systemic

1.3

47.5

5747

36027

L14

ICPC

Leg/thigh symptom/complaint

1.5

47.3

1607

8148

WX726

NOMESCO Finland

High-flow oxygen therapy

140.2

47.2

H26.4

ICD-10 Finland

After-cataract

1.7

47.1

1077

4931

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.0

47.1

292

744

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

47.1

1351

6579

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.7

47.1

351

1006

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.3

47.1

485

1652

Z72.2

ICD-10 Finland

Drug use

3.6

47.0

229

487

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

47.0

3244

18825

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

4.9

47.0

166

260

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

3.3

47.0

255

591

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

46.9

397

1224

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

46.9

894

3875

6BA02

NOMESCO Finland

6.1

46.8

138

174

N06AA06

ATC

trimipramine; systemic

2.0

46.8

624

2376

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

8.9

46.7

107

SPAT1379

SPAT

Health check-up of pregnant person

0.7

46.6

2004

20920

WX212

NOMESCO Finland

Femoral plexus blockade

2.7

46.6

347

993

R52.0

ICD-10 Finland

Acute pain

1.8

46.5

825

3492

N06AX12

ATC

bupropion; oral

1.5

46.3

1959

10416

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.9

46.2

207

410

K85

ICD-10 Finland

Acute pancreatitis

2.7

46.2

348

1003

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

46.1

2045

10978

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

5.4

46.1

148

208

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.8

46.1

317

865

U05

ICPC

Urination problems other

1.9

46.0

749

3077

A02BA04

ATC

nizatidine; systemic

1.5

45.9

1468

7337

L05

ICPC

Flank/axilla symptom/complaint

1.6

45.9

1223

5840

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

45.9

1103

5122

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.1

45.9

135

170

R03DX07

ATC

roflumilast; oral

20.2

45.8

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.1

45.8

582

2175

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.2

45.8

259

619

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

4.1

45.8

193

362

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

45.7

1083

5008

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.0

45.7

287

737

J05AB01

ATC

aciclovir; systemic

1.3

45.7

5701

35849

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

45.7

952

4242

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.2

45.7

500

1752

A03FA02

ATC

cisapride; oral, rectal

1.5

45.5

1558

7914

L84

ICD-10 Finland

Corns and callosities

1.9

45.4

702

2830

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

9.1

45.4

103

P16

ICPC

Acute alcohol abuse

2.3

45.4

446

1484

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.3

45.4

244

562

R28

ICPC

Limited function/disability (R)

3.2

45.3

262

636

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.6

45.1

1282

6228

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

45.1

717

2922

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

45.0

1145

5401

SPAT1380

SPAT

Postpartum check-up

0.7

45.0

1612

17341

E000003

ATC

1.6

44.9

1180

5615

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.5

44.8

227

499

F20

ICD-10 Finland

Schizophrenia

3.4

44.8

233

523

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

44.8

547

2009

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

44.6

1331

6543

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

44.5

5613

35335

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

10.1

44.4

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

44.3

626

2441

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

44.3

995

4535

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.7

44.2

208

430

WF002

NOMESCO Finland

Radical radiotherapy

1.9

44.2

667

2667

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.1

44.1

262

648

F20.0

ICD-10 Finland

Paranoid schizophrenia

3.3

44.1

239

554

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

44.1

926

4136

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

44.0

3625

21592

N05CD08

ATC

midazolam; nasal, systemic

2.3

44.0

434

1447

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.8

44.0

839

3637

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

43.9

1112

5239

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.8

43.8

852

3717

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.4

43.8

406

1313

GDC00

NOMESCO Finland

Lobectomy of lung

6.6

43.8

121

140

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

43.6

1364

6783

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

43.5

754

3165

I95.9

ICD-10 Finland

Hypotension, unspecified

3.3

43.5

232

531

Z08

ICPC

Social welfare problem

2.6

43.4

352

1059

N06AG02

ATC

moclobemide; oral

1.7

43.4

1042

4838

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.9

43.4

285

756

T82

ICPC

Obesity

1.6

43.3

1072

5020

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

12.0

43.3

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.3

43.2

413

1356

WNF00

NOMESCO Finland

Infection source and contact determination

6.1

43.2

127

160

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.0

43.2

611

2383

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.6

43.1

330

961

U02

ICPC

Urinary frequency/urgency

1.3

43.1

3248

19091

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.6

43.1

330

962

R01

ICPC

Pain respiratory system

2.3

43.1

438

1481

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.2

43.0

459

1589

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

43.0

1283

6307

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

2.7

43.0

321

920

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.2

43.0

474

1667

R5110

SPAT

2.2

42.9

482

1708

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

42.9

17464

122602

U07

ICPC

Urine symptom/complaint other

1.6

42.9

1159

5556

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.3

42.8

231

534

A06AH03

ATC

naloxegol; oral

3.4

42.8

224

506

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

42.7

7108

46097

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.5

42.7

217

479

R04

ICPC

Breathing problem other

1.8

42.7

787

3374

K90

ICPC

Stroke/cerebrovascular accident

2.6

42.6

344

1033

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.8

42.6

195

394

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.2

42.6

471

1659

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

42.5

1663

8697

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.8

42.3

298

824

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.2

42.3

242

584

M03BX01

ATC

baclofen; systemic

2.3

42.3

431

1461

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.4

42.3

398

1297

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

9.3

42.2

C02EA02

ATC

2.3

42.2

414

1378

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

42.1

4238

25931

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

42.0

714

2978

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

4.7

42.0

154

252

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

36.9

41.9

M01AB55

ATC

diclofenac, combinations; oral

1.6

41.9

1325

6605

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.1

41.8

514

1894

C01CA24

ATC

epinephrine; parenteral

1.4

41.8

1869

10043

R03BB07

ATC

umeclidinium bromide; inhalant

4.1

41.8

177

334

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.0

41.8

102

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.8

41.8

292

806

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

41.8

2803

16181

B01AF01

ATC

rivaroxaban; oral

1.4

41.7

1905

10280

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.5

41.7

159

271

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.2

41.7

169

306

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.0

41.6

258

658

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.1

41.5

498

1815

K99

ICPC

Cardiovascular disease other

2.4

41.5

373

1186

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.4

41.5

D11

ICPC

Diarrhoea

1.3

41.5

3279

19403

G44.2

ICD-10 Finland

Tension-type headache

1.3

41.5

3773

22772

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.2

41.4

442

1531

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

41.4

457

1608

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.9

41.3

144

223

C08CA05

ATC

nifedipine; systemic

1.6

41.2

1053

4976

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.8

41.1

703

2937

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

41.1

930

4247

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.3

41.0

225

527

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

41.0

560

2156

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.5

41.0

206

451

K56.7

ICD-10 Finland

Ileus, unspecified

2.8

41.0

276

745

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

40.9

932

4264

M01AH02

ATC

rofecoxib; oral

1.4

40.9

2685

15442

R40.2

ICD-10 Finland

Coma, unspecified

3.8

40.8

185

371

P18

ICPC

Medication abuse

3.5

40.8

208

460

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

3.7

40.7

189

387

D07AA02

ATC

hydrocortisone; topical

1.3

40.6

3881

23578

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

40.6

652

2666

D01

ICPC

Abdominal pain/cramps general

1.3

40.6

3038

17832

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.3

40.5

217

499

K02.2

ICD-10 Finland

Caries of cementum

1.7

40.5

844

3760

C10AX09

ATC

ezetimibe; oral

1.4

40.5

1868

10097

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

5.9

40.5

122

159

I20.00

ICD-10 Finland

Unstable angina

2.6

40.5

314

923

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.2

40.4

421

1443

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

4.5

40.4

153

259

M03BX02

ATC

tizanidine; oral

1.2

40.4

20013

142349

C09BA02

ATC

enalapril and diuretics; systemic

1.6

40.3

1190

5835

A10BK03

ATC

empagliflozin; oral

1.5

40.3

1379

7001

Z72.1

ICD-10 Finland

Alcohol use

2.5

40.3

327

986

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.5

40.3

1560

8138

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.8

40.3

759

3278

F34.1

ICD-10 Finland

Dysthymia

1.6

40.3

1008

4733

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

40.3

1326

6674

RS230

NOMESCO Finland

4.0

40.3

173

331

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.4

40.2

379

1237

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

40.2

2325

13097

L95

ICPC

Osteoporosis

2.0

40.1

539

2062

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.2

40.1

228

548

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.6

40.1

148

244

WX290

NOMESCO Finland

Other blockade of nerve

1.2

40.0

15310

106723

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

40.0

1227

6075

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.5

39.9

327

991

J01MA01

ATC

ofloxacin; systemic

1.5

39.9

1596

8388

F20.5

ICD-10 Finland

Residual schizophrenia

4.2

39.8

163

298

D12

ICPC

Constipation

1.9

39.8

580

2289

N06AX05

ATC

trazodone; oral

1.8

39.8

680

2841

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

39.8

832

3712

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.8

39.7

181

365

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

6.5

39.7

111

131

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

39.7

1725

9217

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

39.6

686

2881

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.7

39.5

2299

22982

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.6

39.5

298

863

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.3

39.4

113

138

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

7.0

39.4

104

113

D07AC13

ATC

mometasone; topical

1.2

39.4

7710

50744

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.8

39.4

177

353

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.1

39.3

459

1656

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.7

39.3

860

3890

S01

ICPC

Pain/tenderness of skin

1.7

39.2

942

4375

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.8

39.2

705

2997

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.9

39.2

263

706

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

9.4

39.2

R03AC18

ATC

indacaterol; inhalant

4.8

39.2

139

220

N18

ICPC

Paralysis/weakness

2.6

39.1

302

885

ZX121

NOMESCO Finland

Central venous catheter

4.7

39.1

144

237

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.9

39.1

138

217

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.1

39.1

500

1874

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

39.1

683

2876

C08DA01

ATC

verapamil; systemic

1.8

39.1

735

3174

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

39.0

875

3986

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

39.0

1019

4842

G04BE03

ATC

sildenafil; oral

3.7

39.0

182

375

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

6.1

39.0

114

143

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

3.9

38.9

173

342

Z94.1

ICD-10 Finland

Heart transplant status

7.1

38.9

102

110

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.7

38.8

854

3869

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.3

38.8

155

277

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.8

38.8

2724

26560

B81

ICPC

Anaemia vit B12/folate deficiency

2.0

38.8

562

2215

H36.01

ICD-10 Finland

Diabetic maculopathy

2.8

38.8

265

721

L04AA13

ATC

leflunomide; oral

1.9

38.8

637

2627

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.6

38.7

310

928

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.3

38.7

211

492

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.8

38.7

178

362

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.5

38.7

1656

8822

SPAT1240

SPAT

Therapeutic discussion

1.3

38.7

3469

20885

R07.1

ICD-10 Finland

Chest pain on breathing

2.3

38.7

366

1197

L76

ICPC

Fracture: other

2.0

38.6

516

1970

E000006

ATC

1.4

38.6

1755

9460

M10.0

ICD-10 Finland

Idiopathic gout

2.3

38.6

377

1254

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

6.6

38.6

107

125

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

3.4

38.4

200

451

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.2

38.3

218

525

SPAT1265

SPAT

Breathalyser

2.6

38.3

293

855

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.9

38.3

250

662

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

3.5

38.1

191

418

A10BJ02

ATC

liraglutide; parenteral

2.0

38.0

510

1951

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

38.0

447

1618

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.5

38.0

143

241

A10AE06

ATC

insulin degludec; parenteral

1.7

38.0

761

3353

A10BJ06

ATC

semaglutide; parenteral

1.8

37.9

728

3162

5BA08

NOMESCO Finland

4.4

37.9

146

252

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.1

37.9

128

192

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.2

37.9

400

1380

L12

ICPC

Hand/finger symptom/complaint

1.3

37.9

3768

22995

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.6

37.8

118

161

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.8

37.8

3578

33673

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.9

37.8

243

637

TPX15

NOMESCO Finland

Removal of vascular injection port

4.2

37.7

155

285

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

3.9

37.6

164

319

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

4.3

37.5

151

272

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.6

37.5

291

854

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

6.3

37.5

107

130

SPAT1281

SPAT

Other administrative function

1.4

37.5

1906

10488

G02BA03

ATC

plastic IUD with progestogen

0.8

37.5

2416

23826

4801A

ICD-9 Finland

Viral pneumonia, Pneumonia due to respiratory syncytial virus

+∞

37.5

SPF30

NOMESCO Finland

Soling for prothesis

2.7

37.5

277

792

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

6.6

37.5

103

119

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

13.4

37.4

B82

ICPC

Anaemia other/unspecified

2.2

37.4

402

1398

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.3

37.4

206

485

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.0

37.4

227

573

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.7

37.4

266

744

R09.1

ICD-10 Finland

Pleurisy

2.2

37.3

408

1431

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

7.7

37.3

SPAT1360

SPAT

Extensive global examination

1.5

37.2

1523

8037

1XC02

NOMESCO Finland

3.5

37.1

185

403

L29

ICPC

Musculoskeletal sympt/complt other

1.4

37.1

1697

9157

R4130

NOMESCO Finland

Speech therapy

2.1

37.1

428

1536

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.9

37.0

578

2342

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

37.0

665

2828

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

37.0

24195

175118

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.3

36.9

359

1190

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

36.9

528

2072

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.3

36.9

375

1271

5AB14

NOMESCO Finland

7.5

36.8

SPAT1172

SPAT

Guidance concerning hydration

2.7

36.8

265

746

SPAT1308

SPAT

Sexual health counselling

0.8

36.7

2964

28420

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

36.7

2379

13650

R35

ICD-10 Finland

Polyuria

1.6

36.6

1000

4808

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

36.6

9984

67590

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.7

36.6

796

3595

SPD00

NOMESCO Finland

Fitting and preparation of total teeth prosthesis

3.2

36.5

206

493

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.7

36.5

170

350

N05BA09

ATC

clobazam; oral

3.3

36.5

200

469

J16.0

ICD-10 Finland

Chlamydial pneumonia

38.2

36.5

K85

ICPC

Elevated blood pressure

1.3

36.4

2618

15262

P19

ICPC

Drug abuse

2.5

36.4

310

959

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

4.3

36.4

143

252

602

Kela drug reimbursment

Children's severe malnutrition

4.9

36.4

128

201

H3601, E103

ICD-10 Finland

2.5

36.4

304

932

R06.5

ICD-10 Finland

Mouth breathing

1.4

36.4

2057

11536

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

29010

157124

1.39

323.01

5.2

3.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

1098

1867

3.91

322.10

2.6

e6/l

586.9

498.5

1.69

929

1532

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1704

3910

2.91

317.73

3.3

3.0

nmol/l

0.8

3.17

1320

2995

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

1066

1814

3.91

312.37

2.6

e9/l

0.2

0.18

931

1530

(3014576) Chloride [Moles/volume] in Serum or Plasma

10895

34888

2.26

307.65

10.2

6.3

mmol/l

103.9

104.7

49.54

10595

34222

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

6403

14345

3.15

307.65

1.9

1.5

—

(3002032) Base excess in Venous blood by calculation

9414

24806

2.75

307.65

5.6

3.7

mmol/l

2.1

1.7

23.01

7813

20181

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

894

953

6.24

307.65

2.2

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

6005

17273

2.42

307.65

2.2

1.7

g/l

1.2

1.3

1.88

5479

15822

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7569

28722

1.83

307.65

3.0

2.4

u/l

51.4

43.1

0.35

6483

24609

(3018095) Leukocytes [#/volume] in Urine

24901

112252

1.74

307.65

4.9

3.3

e6/l

87.1

92.1

0.43

18917

76576

(3006315) Basophils [#/volume] in Blood

36568

163468

2.08

307.65

8.5

5.4

e9/l

0.0

0.29

32375

141420

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

24893

127356

1.46

307.65

2.2

1.9

pmol/l

93.0

97.3

36.39

13865

66424

(3027945) Reticulocytes/100 erythrocytes in Blood

9609

30432

2.26

307.65

3.3

2.4

1.9

1.7

37.03

8618

26973

(3020779) Urea [Moles/volume] in Serum or Plasma

9217

23297

2.86

307.65

11.0

6.5

mmol/l

10.4

8.8

65.93

8840

22158

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

6955

16775

2.93

307.65

5.6

3.1

kpa

5.2

5.1

13.25

6505

15489

(3023199) Leukocytes [#/volume] in Pleural fluid

1595

2109

5.07

307.65

1.5

1.4

e6/l

4402.7

2870.4

1.02

1169

1508

(3019198) Lymphocytes [#/volume] in Blood

37142

168551

2.05

307.65

8.6

5.4

e9/l

1.9

2.0

5.70

33352

148719

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

6412

15115

2.98

307.65

1.7

1.4

—

(3018418) pH of Serum or Plasma

21515

88884

1.88

307.65

6.1

3.6

7.4

5.26

4405

16629

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2893

7593

2.57

307.65

4.6

2.8

mg/l

49.2

40.6

1.41

2318

6172

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1098

741

9.89

307.65

1.7

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23135

108713

1.62

307.65

4.2

3.0

u/l

36.3

32.5

3.09

22034

103109

(3022806) Fractional oxyhemoglobin in Capillary blood

1597

3254

3.28

307.65

2.2

1.6

89.5

90.5

8.17

1575

3199

(3002582) Erythrocytes [#/volume] in Urine

22442

93467

1.88

307.65

4.2

2.9

e6/l

71.9

85.7

0.72

18035

70160

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

3194

7802

2.78

307.65

1.9

1.6

—

(3026782) Osmolality of Urine

15645

58749

1.99

307.65

3.5

2.5

mosm/kgh2o

529.3

553.3

27.53

13830

49511

(3023520) Reticulocytes [#/volume] in Blood

7135

22390

2.23

307.65

3.3

2.5

e9/l

72.1

69.1

7.89

5408

16732

(3017181) Myelocytes/100 leukocytes in Blood

7482

25321

2.06

307.65

5.2

3.8

1.0

0.9

0.70

2931

5904

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2643

2233

8.07

307.65

1.7

1.3

—

(3012544) pH of Venous blood

9649

25832

2.71

307.65

5.6

3.7

7.4

0.07

130

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

34426

152350

2.03

307.65

11.0

5.6

mmol/l

1.2

109.24

29613

128156

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3318

2887

7.91

307.65

1.6

1.3

—

(3035880) pH of Pleural fluid

789

871

6.02

307.65

1.3

—

(3023368) Bacteria identified in Blood by Culture

30092

66933

4.64

307.65

5.7

3.5

—

(44790049)

2070

2106

6.64

307.65

1.8

1.4

—

(3000991) Gas panel - Venous blood

8534

22959

2.66

307.65

11.4

7.7

—

(3032080) INR in Blood by Coagulation assay

28770

119699

2.04

307.65

11.3

7.3

inr

1.3

1.2

6.51

8417

35656

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4611

11894

2.67

307.65

1.7

1.5

u/ml

12.4

14.6

0.46

138

321

(3007930) Methemoglobin/Hemoglobin.total in Blood

3780

10565

2.44

307.65

7.4

4.1

0.9

0.26

3523

9927

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2787

2458

7.74

307.65

1.6

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

4108

11034

2.54

307.65

6.5

3.4

mmol/l

25.0

24.6

17.32

3884

10239

(3004809) Band form neutrophils/100 leukocytes in Blood

2002

3908

3.44

307.65

3.9

2.9

1.5

1.4

0.37

1594

2979

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

16316

77342

1.52

307.65

3.1

2.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

20690

76624

2.14

307.65

3.9

2.6

ng/l

1905.0

1066.4

74.56

18184

64020

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1234

1545

5.33

307.65

1.3

u/l

629.0

385.0

2.37

1168

1469

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

893

958

6.20

307.65

2.2

1.6

—

(3012501) Base excess in Blood by calculation

2681

5864

3.09

307.65

5.7

2.9

mmol/l

2.7

2.3

10.72

1976

3691

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

4317

4230

7.11

307.65

1.9

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

5385

16378

2.27

307.65

4.9

3.1

g/l

125.3

131.4

60.92

5237

16030

(3024928) Oxygen saturation in Venous blood

2168

5597

2.60

307.65

4.6

3.5

—

(44790047)

2070

2107

6.64

307.65

1.8

1.4

—

(1616796) Gas panel - Central venous blood

2835

5528

3.48

307.65

4.9

2.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

7852

18951

2.96

307.65

1.9

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

3239

2901

7.67

307.65

1.9

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3270

9799

2.26

307.65

3.0

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

2295

5552

2.78

307.65

4.7

2.8

—

(3009343) pH of Capillary blood

6873

16556

2.93

307.65

5.6

3.1

7.4

0.28

1000

1983

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

11581

39344

2.14

307.65

3.4

2.3

21.1

23.6

60.98

9896

33778

(3009466) Valproate [Moles/volume] in Serum or Plasma

1797

4199

2.86

307.65

5.9

4.9

umol/l

373.0

371.0

0.19

1582

3650

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

710

747

6.31

307.65

2.3

1.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

4392

12658

2.37

307.65

4.8

3.0

mmol/l

25.4

25.1

5.34

4241

12290

(3021901) Oxygen saturation in Capillary blood

2298

4301

3.60

307.65

3.8

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3274

9810

2.26

307.65

3.0

1.9

g/l

7.6

7.2

17.36

2454

7365

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

20083

37717

4.62

307.65

2.2

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

41858

217128

1.75

307.65

5.8

3.9

e6/l

1144.8

1384.3

0.44

724

2750

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1431

1237

7.75

307.65

1.7

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

2556

5365

3.22

307.65

2.9

2.8

umol/l

33.4

34.4

1.04

2202

4546

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

5759

16777

2.38

307.65

12.8

8.3

1.4

8.63

5716

16676

(3021960) Folate [Moles/volume] in Serum or Plasma

15110

69349

1.56

307.65

1.7

1.5

nmol/l

19.4

20.6

18.16

13395

59533

(3000850) Epithelial cells [#/volume] in Urine

16438

63725

1.93

307.65

3.3

2.4

e6/l

6.1

5.7

2.53

14797

55099

(3012095) Magnesium [Moles/volume] in Serum or Plasma

14893

45718

2.48

307.65

4.9

3.1

mmol/l

0.8

30.16

14017

42636

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3265

9782

2.26

307.65

3.0

1.9

g/l

3.9

3.8

0.56

2365

6986

(40768806) Pleura Pathology biopsy report

1282

1874

4.57

307.65

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

47068

252829

1.81

307.65

11.3

6.6

u/l

82.3

76.6

102.06

45244

237501

(3021440) Promyelocytes/100 leukocytes in Blood

6918

24336

1.97

307.65

5.4

3.9

0.1

1.21

2708

5478

(3026008) Bacteria identified in Urine by Culture

21481

90409

1.84

307.65

3.7

2.7

—

(3020891) Body temperature

3549

10626

2.26

307.65

7.0

4.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

1927

4029

3.21

307.65

2.3

1.6

mmol/l

1.6

1.8

10.83

1887

3930

(3028308) Erythrocytes [#/volume] in Pleural fluid

1448

1910

5.07

307.65

1.5

1.4

e6/l

38685.3

60054.0

1.89

880

1121

(3015235) Bicarbonate [Moles/volume] in Capillary blood

3076

6124

3.42

307.65

4.4

2.5

mmol/l

25.0

24.2

14.85

2720

5398

(3026493) Urate [Moles/volume] in Serum or Plasma

17256

83189

1.49

307.65

3.7

2.3

umol/l

3207.4

4225.9

3.19

15188

72732

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3970

7510

3.64

307.65

3.8

3.2

u/ml

0.3

0.4

6.25

2360

4134

(3010421) pH of Blood

3015

6841

2.99

307.65

5.7

2.9

7.4

2.61

2629

5733

(3027135) IgG subclass 1 [Mass/volume] in Serum

1431

2811

3.40

307.65

1.4

1.3

g/l

6.7

0.18

1041

1905

(3027315) Oxygen [Partial pressure] in Blood

2702

5897

3.10

307.65

5.7

2.9

kpa

8.4

8.9

29.30

2645

5764

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

6080

21225

1.97

307.65

5.3

3.6

ng/l

109.4

82.7

46.93

5358

18398

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

5762

16738

2.39

307.65

12.9

8.4

0.7

2.23

5722

16649

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2333

3917

4.02

307.65

4.0

2.7

u/ml

5150.4

5505.9

0.03

161

194

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

9198

35386

1.83

307.65

3.4

2.6

umol/l

8.2

8.3

0.13

7922

30592

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1786

3060

3.92

307.65

7.4

5.8

mg/l

11.6

11.1

4.44

1636

2832

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1636

844

13.04

307.65

1.9

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

12460

36378

2.55

307.65

8.8

5.2

mmol/l

1.1

1.0

18.05

11757

33960

(3018010) Neutrophils/100 leukocytes in Blood

34876

156568

2.00

307.65

8.6

5.3

59.4

56.2

307.65

33231

146487

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

26041

113610

1.85

307.65

4.7

3.0

ng/l

70.6

58.2

0.48

18793

69546

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

15537

55353

2.11

307.65

4.8

3.2

ng/l

426.2

532.6

1.60

12224

39292

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

5494

7771

4.98

307.65

2.3

1.8

ug/l

2.3

0.03

4938

6779

(3022217) INR in Platelet poor plasma by Coagulation assay

9846

35851

1.95

307.65

25.7

21.4

inr

1.4

1.3

7.46

1381

5313

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2947

7643

2.61

307.65

1.6

1.4

iu/ml

19.0

11.9

1.56

157

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3017

5194

3.96

307.65

7.7

4.9

iu/ml

2617.1

813.5

0.78

528

664

(4062490)

1437

2808

3.42

307.65

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1518

1527

6.67

307.65

1.9

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

2501

5451

3.10

307.65

3.3

2.1

16.1

17.0

18.15

1347

2740

(3013826) Glucose [Moles/volume] in Serum or Plasma

39455

186979

1.98

307.65

7.7

4.0

mmol/l

6.9

6.6

104.54

37608

172506

(3002173) Hemoglobin [Mass/volume] in Arterial blood

9072

24491

2.67

307.65

11.0

7.3

g/l

120.6

122.6

13.88

8736

23618

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

14718

24680

4.77

307.65

2.1

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

30370

132924

1.94

307.65

6.9

4.3

g/l

34.1

36.3

307.65

28508

123183

(3000494) Fungus identified in Specimen by Culture

9283

36100

1.81

307.65

1.8

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

1759

2316

5.10

307.65

1.5

1.4

g/l

32.9

33.9

1.97

1573

2118

(44806118)

2070

2107

6.64

307.65

1.8

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2494

6128

2.74

307.65

2.6

2.0

g/l

127.9

132.9

14.74

1811

4526

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2821

7359

2.59

307.65

4.5

2.8

ratio

6.6

2.7

0.86

215

593

(3020630) Protein [Mass/volume] in Serum or Plasma

7250

21281

2.39

307.65

3.3

2.3

g/l

65.1

67.2

81.80

6694

19348

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

17605

69177

1.92

307.65

2.3

1.7

mg/l

1.3

1.1

10.54

14051

51366

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

3079

4311

4.88

307.65

1.7

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1515

927

10.97

307.65

1.2

1.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

12684

52587

1.73

307.65

3.3

2.6

e6/l

1.4

1.1

0.72

7236

29441

(3006504) Eosinophils/100 leukocytes in Blood

34689

152469

2.06

307.65

8.8

5.5

2.6

2.9

98.18

33026

141876

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1097

727

10.07

307.65

1.7

1.2

—

(3011412) CD3 cells [#/volume] in Blood

1497

2523

3.97

307.65

2.5

2.4

e9/l

1.2

0.94

933

1473

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

4069

9839

2.83

307.65

2.2

1.6

—

(3022096) Basophils/100 leukocytes in Blood

33966

147418

2.08

307.65

8.8

5.6

0.6

0.7

142.38

32361

137200

(3037467) Urinalysis macro (dipstick) panel - Urine

42171

231267

1.57

307.65

5.7

3.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

7611

22438

2.39

307.65

3.7

2.4

g/l

10.1

10.7

15.96

7060

20468

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7916

28719

1.92

307.65

2.5

2.1

nmol/l

361.2

377.6

8.45

7322

26506

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

22939

99423

1.80

307.65

3.3

2.4

u/l

55.2

58.8

11.08

21509

91419

(3014007) Fractional oxyhemoglobin in Arterial blood

5784

16834

2.38

307.65

12.9

8.5

92.9

94.4

52.80

5759

16780

(3025159) Blasts/100 leukocytes in Blood

6353

23270

1.88

307.65

5.4

3.9

0.1

0.3

3.55

2279

4681

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

5623

13087

3.00

307.65

11.6

9.1

mmol/l

24.7

24.1

29.26

5191

12340

(3047181) Lactate [Moles/volume] in Blood

3255

8229

2.68

307.65

8.2

4.6

mmol/l

1.3

2.90

2906

7240

(3028626) Oxygen [Partial pressure] in Capillary blood

3045

6374

3.25

307.65

5.4

3.5

kpa

8.2

8.8

40.98

2843

5966

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

7470

21146

2.49

307.65

3.7

2.4

ng/l

242.2

166.1

27.97

6848

19058

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

4819

6615

5.09

307.65

3.0

2.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2673

2154

8.46

307.65

1.6

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1166

2016

3.85

307.65

2.0

2.2

13.2

13.6

0.33

586

998

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3885

11899

2.22

307.65

5.5

3.4

51.3

47.9

12.57

3841

11775

(3033658) Prothrombin time (PT) actual/Normal

18672

80176

1.74

307.65

5.7

3.6

88.2

92.1

78.07

18190

78118

(36304419) Bacteria [Presence] in Urine

20070

83965

1.83

307.65

4.0

2.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

703

731

6.38

307.65

2.3

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2151

1873

7.77

307.65

1.9

1.4

—

(3019069) Monocytes/100 leukocytes in Blood

34850

153351

2.06

307.65

9.2

5.7

8.6

8.5

8.28

33279

143526

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1800

2156

5.62

307.65

1.9

1.5

—

(3001604) Monocytes [#/volume] in Blood

36445

162693

2.08

307.65

8.4

5.4

e9/l

0.6

241.19

32241

140837

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

31962

137198

2.05

307.65

10.0

5.1

mmol/l

1.2

147.23

29716

123892

(3044640) Blood type and Crossmatch panel - Blood

21216

102073

1.54

307.65

3.2

2.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

3496

9555

2.48

307.65

1.7

1.6

titre

344.9

267.9

0.69

150

373

(3016502) Oxygen saturation in Arterial blood

10207

25908

2.89

307.65

10.2

7.0

94.7

96.3

91.28

9785

24988

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

11941

54337

1.54

307.65

3.6

2.8

mmol/l

2.5

2.4

76.12

10417

47442

(3018405) Lactate [Moles/volume] in Arterial blood

3259

9041

2.44

307.65

5.5

3.7

mmol/l

1.4

0.08

3193

8898

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1697

1882

6.06

307.65

2.0

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

10685

30952

2.52

307.65

5.1

3.9

u/l

249.3

239.1

7.51

10197

29223

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1719

2533

4.55

307.65

1.2

1.1

—

(42870588) Differential panel, method unspecified - Blood

27495

107588

2.18

307.65

8.2

5.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

1182

2045

3.85

307.65

2.1

2.2

72.7

72.8

0.09

1130

1980

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7618

29763

1.77

307.65

4.6

2.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1218

841

9.68

307.65

1.6

1.2

—

(3019060) Gas panel - Arterial blood

7118

15626

3.24

307.65

6.2

4.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2238

5777

2.60

307.65

1.7

1.5

—

(3023419) Bacteria identified in Sputum by Culture

2241

1947

7.80

307.65

3.1

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1518

1527

6.67

307.65

1.9

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

12192

42778

2.07

307.65

3.3

2.2

g/l

2.3

2.4

91.86

11388

39446

(3024980) IgG subclass 4 [Mass/volume] in Serum

1946

4686

2.78

307.65

1.6

g/l

0.7

0.8

0.68

1464

3538

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

36664

162596

2.11

307.65

8.6

5.4

umol/l

10.9

11.4

10.03

35087

153362

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2548

1959

8.86

307.65

1.5

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

894

953

6.24

307.65

2.2

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

3300

9097

2.46

307.65

3.4

2.6

g/l

3.9

3.5

31.47

3169

8655

(3002179) Metamyelocytes/100 leukocytes in Blood

6726

23172

2.01

307.65

5.0

3.7

0.7

0.6

0.59

2110

4305

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

4116

12367

2.27

307.65

4.2

2.8

0.7

0.08

3998

11819

(3013115) Eosinophils [#/volume] in Blood

37413

169159

2.07

307.65

9.0

5.6

e9/l

0.2

1.01

33507

148678

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

4225

3313

8.90

307.65

1.4

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

974

1222

5.30

307.65

1.3

u/l

15.4

13.1

1.30

877

1150

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

2100

4802

2.94

307.65

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

43634

249494

1.45

307.65

5.4

3.7

mm/h

15.6

10.5

307.65

41022

231432

(3034860) Kappa light chains.free [Mass/volume] in Serum

2892

7610

2.57

307.65

4.6

2.8

mg/l

60.5

60.7

0.01

2322

6177

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

11548

28756

2.99

307.65

9.6

6.7

kpa

5.1

11.43

10933

27593

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

4260

12569

2.31

307.65

4.2

2.8

1.4

1.3

6.84

4244

12504

(3014111) Lactate [Moles/volume] in Serum or Plasma

8787

23472

2.69

307.65

9.4

6.6

mmol/l

1.4

1.3

4.52

8396

22713

(44790048)

2070

2108

6.63

307.65

1.8

1.4

—

(40758558) Short blood count panel - Blood

19168

80613

1.80

307.65

10.1

6.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

18477

76961

1.81

307.65

2.6

2.2

mg/l

3.1

2.8

42.29

16115

65689

(3039000) Anion gap in Blood

2307

5682

2.73

307.65

9.6

5.5

mmol/l

11.3

11.2

0.35

2068

5134

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1674

1484

7.58

307.65

4.1

3.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

11542

28740

2.99

307.65

9.6

6.7

kpa

11.1

13.3

307.65

10914

27578

(3021589) Normoblasts [#/volume] in Blood

29110

148653

1.52

307.65

14.1

8.3

e9/l

0.0

1.02

23935

122158

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

6278

17383

2.52

307.65

9.6

7.0

mmol/l

25.1

24.6

17.42

6217

17246

(3022313) Gas panel - Capillary blood

4848

12160

2.75

307.65

6.1

3.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3066

9133

2.27

307.65

3.0

1.9

g/l

10.2

0.25

2567

7646

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

729

793

6.10

307.65

4.5

3.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2682

5865

3.09

307.65

5.7

2.9

kpa

5.0

4.08

2626

5732

(3002030) Lymphocytes/100 leukocytes in Blood

35449

158800

2.03

307.65

8.9

5.5

25.6

29.3

307.65

33734

147861

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

4515

11556

2.69

307.65

1.9

1.7

g/l

1.6

1.5

23.11

3914

9837

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3877

10740

2.46

307.65

7.2

4.1

1.8

1.7

8.07

3604

10098

(3024354) Oxygen [Partial pressure] in Venous blood

7447

20865

2.52

307.65

4.9

3.1

kpa

4.8

4.6

5.38

7137

20293

(3036782) Glucose [Moles/volume] in Pleural fluid

1243

1715

4.84

307.65

1.4

1.3

mmol/l

6.4

6.2

1.19

1135

1603

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3079

9274

2.24

307.65

3.1

2.0

g/l

3.2

3.0

27.07

2402

7207

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1006

1337

5.01

307.65

1.5

1.4

u/l

12.7

12.3

1.02

965

1304

(3018677) aPTT in Platelet poor plasma by Coagulation assay

12477

44892

2.02

307.65

2.8

2.0

30.2

29.6

16.94

12100

43610

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1122

1874

3.99

307.65

2.1

2.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1377

2637

3.48

307.65

4.5

3.1

—

(3003396) Base excess in Arterial blood by calculation

11532

28778

2.99

307.65

9.6

6.7

mmol/l

1.5

0.7

65.86

9276

22435

(3037692) Legionella sp identified in Specimen by Organism specific culture

827

401

13.72

307.65

1.6

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

14646

24596

4.76

307.65

2.1

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

4226

3315

8.89

307.65

1.4

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

5406

14191

2.64

307.65

13.1

8.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

704

731

6.39

307.65

2.3

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3740

9044

2.82

307.65

2.8

2.2

ug/l

615.9

489.4

0.69

3518

8390

(3018572) Chloride [Moles/volume] in Blood

2307

5683

2.73

307.65

9.6

5.5

mmol/l

104.5

105.5

12.90

2068

5136

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

894

953

6.24

307.65

2.2

1.6

—

(3045788) Cell count panel - Pleural fluid

1235

1624

5.08

307.65

1.5

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

5430

13137

2.87

307.65

6.0

4.2

mmol/l

24.3

24.0

10.47

4946

11838

(3037756) Immunofixation for Serum or Plasma

2103

4775

2.96

307.65

2.0

1.6

—

(3042936) Bacteria identified in Isolate by Culture

12934

40761

2.36

307.65

2.5

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

20612

85565

1.85

307.65

4.1

2.8

e6/l

0.5

0.4

12.38

16229

62917

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

6690

15974

2.95

307.65

5.5

3.1

mmol/l

2.1

1.3

40.22

5154

11363

(3008152) Bicarbonate [Moles/volume] in Arterial blood

6126

15823

2.71

307.65

9.7

6.1

mmol/l

25.0

24.4

24.18

5724

14719

(3021447) Carbon dioxide [Partial pressure] in Venous blood

9407

24930

2.73

307.65

5.6

3.7

kpa

5.9

5.8

12.44

9073

24313

(3042631) Mycobacterium sp identified in Specimen

1857

2696

4.63

307.65

3.1

2.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

1432

2806

3.41

307.65

1.4

1.3

g/l

2.7

3.1

10.94

1042

1903

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

12162

48742

1.79

307.65

3.5

2.7

e6/l

3.1

3.0

0.31

6736

25782

(3015377) Calcium [Moles/volume] in Serum or Plasma

21947

104691

1.57

307.65

4.4

3.1

mmol/l

2.3

2.4

46.70

19486

91742

(3024139) IgG subclass 3 [Mass/volume] in Serum

1431

2805

3.41

307.65

1.4

1.3

g/l

0.4

0.55

1043

1909

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7871

27494

2.00

307.65

2.5

2.3

g/l

0.2

35.22

7270

25688

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1518

1527

6.67

307.65

1.9

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

5588

17517

2.20

307.65

3.2

2.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

21029

91868

1.75

307.65

2.7

2.0

u/l

260.2

198.6

7.24

19896

86188

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3710

6927

3.67

307.65

1.2

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

40251

189309

2.04

307.65

13.8

8.0

e9/l

4.6

4.0

307.65

36091

164794

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

4164

4123

7.02

307.65

1.9

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

3381

6681

3.45

307.65

1.4

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

10439

36179

2.07

307.65

2.1

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

4555

10680

2.94

307.65

2.5

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

12952

46871

2.02

307.65

3.3

2.3

umol/l

11.8

14.4

8.28

12108

43413

(3012441) Differential panel - Pleural fluid

1357

1813

5.00

307.65

1.5

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6795

22979

2.05

307.65

2.7

2.1

ug/l

7.7

7.3

0.59

5859

20142

(3019309) Folate [Moles/volume] in Red Blood Cells

13246

52600

1.82

307.65

1.9

1.7

nmol/l

1167.4

1166.1

0.05

10320

39765

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

646

709

6.04

306.91

1.9

1.5

u/ml

26207.9

24619.7

0.03

(3015736) pH of Urine

24212

128063

1.39

305.11

4.1

3.1

5.8

0.03

(3043409) Potassium [Moles/volume] in Arterial blood

2692

7925

2.29

304.98

6.1

3.9

mmol/l

3.9

0.59

2482

7507

(4010399)

5692

21965

1.77

303.58

1.6

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

56746

347442

1.58

299.87

26.6

10.7

mg/l

31.6

20.9

307.65

51293

265338

(21494815) CD4 cells/100 lymphocytes in Specimen

1232

2395

3.43

299.71

2.3

2.2

37.1

42.9

3.15

128

331

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2780

8370

2.24

298.75

3.2

2.1

g/l

1.0

0.8

1.52

2399

7219

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2983

9320

2.16

292.91

1.9

1.7

g/l

0.2

0.84

2827

8848

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

25398

136077

1.37

291.65

2.7

2.2

nmol/l

75.0

739.8

0.50

23191

123582

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

2025

5340

2.54

290.67

1.3

1.2

titre

177.9

114.0

0.55

(3052851) Hemolysis interference index of Serum or Plasma

2839

8732

2.19

289.68

4.0

2.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3132

10028

2.11

289.02

3.2

2.4

91.3

92.8

2.80

2998

9263

(3001122) Ferritin [Mass/volume] in Serum or Plasma

27836

151484

1.36

288.85

3.6

2.7

ug/l

170.3

106.3

74.83

25986

141285

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3036

9627

2.13

287.12

1.9

1.6

g/l

1.2

1.31

2882

9177

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1072

1955

3.65

285.89

2.7

2.5

e6/l

777.2

715.7

0.23

432

761

(40757373) Influenza virus identified in Isolate

407

272

9.89

282.16

1.8

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

29988

165488

1.35

281.95

4.5

3.3

estimate

0.0

0.37

6135

30366

(3037522) Nuclear Ab [Titer] in Serum

10078

45823

1.53

279.55

1.4

1.3

titre

550.8

539.6

0.22

2180

8892

(3026250) Tacrolimus [Mass/volume] in Blood

784

1142

4.56

278.20

40.5

34.9

ug/l

7.4

7.3

0.18

719

1045

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

516

490

6.97

277.99

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1026

1877

3.63

272.38

19.2

18.7

nmol/l

2225.8

2682.8

0.15

980

1797

(3036489) Thrombin time

3498

11928

1.98

272.13

2.8

2.1

21.7

21.4

1.64

3144

10213

(3009261) Glucose [Presence] in Urine by Test strip

30224

167678

1.35

269.62

4.5

3.3

estimate

0.0

0.25

6076

30382

(40760892) CBC W Ordered Manual Differential panel - Blood

15300

76044

1.42

268.63

6.3

4.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2474

7437

2.23

266.33

2.9

2.0

g/l

0.0

1.09

2270

6808

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2267

6566

2.32

265.99

1.7

1.4

u/ml

20.2

19.3

0.12

110

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2279

6621

2.31

265.54

1.7

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

5417

21396

1.72

264.63

1.5

1.2

u/ml

258.9

243.9

0.41

5016

19818

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1699

4298

2.64

264.52

1.6

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

751

1102

4.52

264.23

33.0

24.8

ug/l

118.1

121.3

0.45

618

926

(3021601) Nitrite [Presence] in Urine by Test strip

29891

166032

1.34

261.17

6.0

4.5

estimate

0.0

0.51

6308

31223

(3010503) CD19 cells [#/volume] in Blood

884

1498

3.92

260.38

2.8

2.5

e9/l

0.4

0.2

1.17

861

1465

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2511

7668

2.20

260.21

2.8

1.9

g/l

36.3

38.5

47.18

2196

6577

(3003181) Sodium [Moles/volume] in Urine

1695

4329

2.62

259.01

1.6

1.4

mmol/l

62.2

64.5

1.16

1306

3452

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

971

1785

3.61

256.00

13.7

13.5

nmol/l

839.2

1672.2

0.73

939

1725

(3009508) Creatinine [Moles/volume] in Urine

19159

99606

1.37

255.67

3.8

3.2

mmol/l

7.4

8.0

4.63

16333

84337

(3020682) Albumin/Creatinine [Ratio] in Urine

18170

93687

1.38

254.89

4.6

3.9

mg/mmol

15.8

7.9

40.68

12213

58902

(3008536) Aspergillus sp Ab [Presence] in Serum

411

325

8.36

254.71

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6875

29212

1.61

253.71

3.9

4.0

ug/l

20.4

25.9

0.80

5669

22996

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2837

9196

2.07

252.84

3.2

2.5

201.0

178.4

29.87

2724

8679

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2298

6846

2.25

252.50

2.9

2.0

g/l

0.0

0.31

2098

6242

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2633

8314

2.13

251.03

5.6

4.0

mg/l

1.7

1.4

55.02

2451

7706

(3012516) Albumin [Mass/volume] in Urine

17361

89132

1.38

248.63

3.8

3.2

mg/l

625.1

367.2

7.80

11857

55718

(3017354) Segmented neutrophils/100 leukocytes in Blood

1159

2448

3.15

247.90

3.9

2.9

60.1

56.9

3.58

772

1545

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2261

6759

2.24

246.34

2.9

2.0

g/l

0.0

0.00

2090

6226

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

2087

6137

2.28

236.17

1.7

1.4

u/ml

115.2

108.8

0.80

419

1411

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

820

1467

3.71

224.51

2.7

38.6

40.5

1.11

302

469

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

2202

6788

2.17

222.50

1.4

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1540

4045

2.54

222.32

1.8

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5805

24519

1.61

217.40

5.9

3.2

mmol/l

1.2

18.72

5307

21153

(3007164) IgA [Mass/volume] in Serum or Plasma

13532

68058

1.39

213.29

1.8

1.4

g/l

2.5

2.3

11.80

8811

41367

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

2084

6396

2.18

212.75

1.4

1.3

u/ml

284.5

250.7

5.24

1358

4075

(3019550) Sodium [Moles/volume] in Serum or Plasma

56392

349359

1.46

211.89

28.4

12.3

mmol/l

139.2

139.7

307.65

55417

340062

(3019977) pH of Arterial blood

713

1210

3.91

209.59

2.8

2.3

7.4

1.13

237

412

(3017143) Hepatitis C virus Ab [Presence] in Serum

9160

43082

1.46

209.02

1.9

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

14931

76528

1.37

208.78

4.2

3.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

56482

350444

1.45

204.43

28.6

12.4

mmol/l

4.0

38.58

55407

340431

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

789

1472

3.55

203.66

1.5

1.3

—

(4035726)

6089

26502

1.56

199.93

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

774

1447

3.55

199.20

1.5

1.3

—

(3028433) Virus identified in Specimen by Culture

540

761

4.69

199.00

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2439

8162

2.00

198.64

2.1

2.0

mg/l

11.6

10.5

4.27

2282

7640

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1196

2953

2.69

194.74

2.0

1.9

ug/l

22.4

25.6

1.01

1170

2893

(3023383) Lactate [Moles/volume] in Pleural fluid

429

495

5.73

194.55

1.3

mmol/l

3.3

3.6

0.56

386

464

(3006245) CD3-CD19+ cells/100 cells in Blood

652

1094

3.95

194.54

2.2

2.5

11.1

10.9

0.14

601

1034

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1022

2318

2.93

194.01

3.4

2.5

—

(3000492) Spirometry study

7160

32563

1.50

191.68

1.7

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

12925

65484

1.37

191.53

1.7

1.6

pmol/l

34852842.9

35933899.3

0.07

10840

54651

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3469

13193

1.77

190.90

2.1

2.0

u/l

38.7

39.7

2.25

3074

11854

(3042733) HLA Ab [Presence] in Serum

578

906

4.22

187.99

5.1

4.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

306

246

8.21

187.49

2.5

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1627

4754

2.28

186.42

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

630

1069

3.90

185.25

2.0

2.3

30.1

28.2

2.15

590

1028

(3013512) EKG study

16734

88625

1.32

183.66

4.7

3.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1950

6180

2.11

183.38

3.9

3.2

e9/l

4.5

3.9

22.23

1945

6169

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

929

2095

2.94

178.10

1.5

1.2

u/ml

1.7

0.9

1.77

550

737

(3048929) Epstein Barr virus Ab [Presence] in Serum

3103

11778

1.77

171.42

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

615

1088

3.74

171.02

3.9

2.9

—

(1761868) Lipid panel - Serum or Plasma

16534

131634

0.77

169.56

2.9

2.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2479

8833

1.88

167.79

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1975

6505

2.03

167.63

1.6

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

445

625

4.71

164.68

1.4

54.9

65.9

6.50

359

523

(3017569) Oxygen content in Arterial blood

566

970

3.86

164.29

2.1

2.2

—

(4015189)

401

513

5.16

164.13

2.9

1.8

—

(3044889) 12 lead EKG panel

38696

229876

1.26

163.64

4.5

3.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

1589

4858

2.18

163.37

4.8

3.3

65.0

65.1

0.05

1581

4840

(3037121) Protein [Mass/volume] in Urine

2766

10288

1.80

163.34

3.8

3.2

g/l

0.4

0.3

3.42

1452

4502

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2707

10080

1.80

159.18

1.6

iu/ml

2.6

7.0

0.76

654

2005

(3040151) Glucose [Moles/volume] in Capillary blood

1134

3061

2.46

154.53

15.4

4.5

mmol/l

7.4

7.2

0.61

964

2464

(3016228) CD19 cells/100 cells in Blood

563

1012

3.68

153.20

2.1

2.0

8.8

8.4

0.20

551

988

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5958

27280

1.48

151.92

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

595

1119

3.52

151.88

1.6

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2579

9604

1.80

151.49

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

594

1119

3.51

151.26

1.6

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

552

992

3.68

150.27

2.1

2.0

—

(21494755) Public health laboratory ask at order entry panel

4250

41497

0.65

147.85

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

333

399

5.51

145.69

1.4

26.2

19.8

2.64

269

348

(46235355) HIV 1 and 2 tests - Meaningful Use set

13886

73620

1.30

144.54

2.0

1.9

—

(3045142) Bone marrow Pathology biopsy report

1045

2814

2.46

143.11

1.5

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3796

15972

1.60

141.77

3.5

2.5

e6/l

0.3

2.13

3706

15498

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

209

145

9.50

141.64

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

460

758

4.01

140.60

2.0

1.9

—

(3000060) B lymphocytes [#/volume] in Blood

490

848

3.82

140.45

2.0

2.4

e6/l

393.8

592.1

0.27

297

443

(3029937) Albumin [Presence] in Urine by Test strip

16384

89051

1.28

140.02

5.1

3.6

estimate

0.0

0.55

5881

30270

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

270

269

6.62

139.91

1.4

1.1

—

24.3

—

(3024471) HLA-A [Type]

521

948

3.63

139.42

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

932

2409

2.57

138.77

1.2

titre

235.5

179.0

0.31

(3044242) Glucose [Moles/volume] in Arterial blood

554

1057

3.47

138.52

2.2

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

933

2417

2.56

138.30

1.2

titre

175.6

195.5

0.29

150

405

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

17296

94788

1.27

137.77

4.3

4.7

ug/l

3.2

3.0

0.26

15504

85703

(21494890) Protein electrophoresis panel - 24 hour Urine

964

2543

2.51

137.75

2.7

1.8

—

(3046861) Legionella sp Ag [Presence] in Urine

137

22.01

137.45

1.1

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

179

101

11.68

137.11

1.9

1.6

umol/l

47.2

44.8

0.30

179

101

(40768446) Kidney Pathology biopsy report

568

1112

3.38

136.71

1.9

1.7

—

(3024932) HLA-DR beta [Type]

510

928

3.63

136.49

1.1

—

(3051651) Icteric interference index of Serum or Plasma

714

1615

2.93

136.20

4.8

3.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

457

777

3.89

134.13

1.9

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

195

135

9.52

132.35

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1410

4480

2.09

131.42

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

990

2711

2.42

130.85

1.4

1.6

mosm/kgh2o

279.4

280.7

0.79

770

2124

(3017704) Immunofixation for Urine

592

1225

3.20

130.85

1.9

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

597

1244

3.17

130.50

1.3

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2329

8801

1.77

129.95

1.4

ug/g

264.4

281.6

3.25

1360

4988

(3013727) Leukocytes other/100 leukocytes in Blood

440

747

3.89

129.41

4.4

2.9

54.2

50.7

2.12

428

721

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7104

61835

0.73

129.15

1.5

—

(3025941) Bacteria identified in Stool by Culture

4398

19557

1.51

128.15

1.3

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3773

36726

0.66

127.82

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

1263

3907

2.15

125.99

1.6

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

400

644

4.10

125.98

1.3

1.2

92.3

91.5

0.19

395

632

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

448

793

3.73

124.60

3.4

2.9

—

(40761535) Cells panel - Urine sediment

5398

25160

1.45

124.18

4.3

3.2

—

(40768797) Stomach Pathology biopsy report

8755

44286

1.35

124.16

1.3

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

395

641

4.07

123.18

1.3

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

788

1992

2.62

122.61

2.4

1.6

mg/l

4.5

3.3

7.07

746

1904

(3017817) Protein [Mass] in Urine collected for unspecified duration

898

2429

2.45

121.83

2.8

2.5

0.2

0.7

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

670

1558

2.85

121.79

2.6

2.4

u/ml

1272.7

882.4

2.56

662

1543

(3035947) Staphylolysin Ab [Units/volume] in Serum

603

1326

3.01

120.73

1.2

1.1

iu/ml

4.4

3.7

0.65

113

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

39094

236099

1.22

119.98

4.0

2.9

u/l

58.5

43.7

129.59

36854

221972

(3006576) Bicarbonate [Moles/volume] in Blood

445

823

3.57

116.46

7.1

5.7

mmol/l

25.0

25.1

0.12

394

757

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

583

1287

3.00

115.99

2.1

umol/l

129.1

142.9

0.39

287

662

(3020876) Protein [Mass/time] in 24 hour Urine

832

2223

2.48

115.83

2.2

1.9

g/24h

1.3

0.9

0.47

140

(3001893) Eosinophils/100 leukocytes in Pleural fluid

356

559

4.20

115.71

1.3

1.4

2.9

2.7

0.11

297

476

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

332

492

4.45

115.68

1.3

ug/l

150.1

389.8

1.48

183

253

(3019225) pH of Specimen

6175

29859

1.40

115.26

6.4

3.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

926

2625

2.34

113.50

1.8

1.4

promille

1.3

1.4

1.01

712

2029

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

977

2848

2.27

112.40

1.6

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

22556

129475

1.22

112.38

4.8

3.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1423

4820

1.96

111.42

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

249

292

5.62

111.37

1.7

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

553

1213

3.01

111.23

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

553

1214

3.01

111.08

1.7

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1079

3296

2.17

111.04

1.3

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1136

3553

2.12

110.21

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1018

3055

2.21

109.37

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

504

1058

3.15

108.96

2.9

2.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2089

22412

0.60

108.28

1.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

282

385

4.83

107.86

1.3

1.4

ng/l

112.5

325.6

0.41

204

216

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

312

467

4.41

107.48

5.8

5.9

—

(3052592) Norovirus Ag [Presence] in Stool

288

404

4.70

106.90

1.5

1.2

—

(3019150) Specific gravity of Urine by Refractometry

13368

72804

1.26

106.86

4.9

3.6

kg/l

1.0

0.58

1982

10928

(3032743) Legionella sp IgG Ab [Presence] in Serum

155

105

9.72

106.73

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

200

193

6.83

106.56

1.5

1.7

mg/l

1.9

1.5

0.40

133

127

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

197

187

6.94

106.40

1.5

1.7

mg/l

1.1

0.7

0.73

130

129

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

197

187

6.94

106.40

1.5

1.7

mg/l

3.6

4.1

0.32

129

119

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

197

187

6.94

106.40

1.5

1.7

mg/l

2.8

2.6

0.16

139

135

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

197

187

6.94

106.40

1.5

1.7

mg/l

1.2

1.3

0.10

128

116

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

197

187

6.94

106.40

1.5

1.7

mg/l

2.2

2.0

0.15

133

123

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

197

187

6.94

106.40

1.5

1.7

mg/l

1.8

1.6

0.28

144

131

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

197

187

6.94

106.40

1.5

1.7

mg/l

1.6

2.1

0.62

121

113

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

197

187

6.94

106.40

1.5

1.7

mg/l

2.4

1.8

0.62

147

139

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

197

187

6.94

106.40

1.5

1.7

mg/l

2.5

2.9

0.38

136

132

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

389

698

3.68

106.27

3.3

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

389

698

3.68

106.27

3.3

2.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1182

3824

2.05

105.02

2.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2007

7734

1.73

104.37

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1188

3866

2.04

103.91

1.7

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

458

936

3.23

103.34

2.5

2.0

ug/l

61.5

64.8

0.32

452

911

(3000093) Morphology [Interpretation] in Blood Narrative

909

2669

2.26

102.85

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1164

3775

2.05

102.74

1.7

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

767

2089

2.43

102.60

1.3

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

320

509

4.15

102.42

1.3

1.4

27.4

18.4

5.29

291

464

(21494567) Legionella sp IgM Ab [Presence] in Serum

156

114

9.01

102.28

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2443

24939

0.63

102.11

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

999

3061

2.16

102.04

1.3

1.2

u/l

71.0

65.4

0.41

740

2012

(3044927) Protein electrophoresis panel - Urine

839

2389

2.33

101.84

1.2

—

(21494434) Karyotype in Bone marrow

792

2201

2.38

101.45

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1157

3775

2.03

100.49

1.7

1.3

—

(3045716) Anion gap in Serum or Plasma

509

1130

2.98

100.37

2.6

2.4

mmol/l

9.0

9.4

1.43

379

815

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1147

3735

2.04

100.15

1.7

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1145

3732

2.03

99.72

1.7

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1144

3730

2.03

99.54

1.7

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1384

4873

1.89

96.67

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

2216

8954

1.65

96.60

1.2

titre

829.4

945.7

0.34

251

(3007566) Smooth muscle Ab [Titer] in Serum

2250

9127

1.64

96.60

1.2

1.3

titre

112.4

120.2

0.21

217

827

(3014891) Appearance of Pleural fluid

190

196

6.39

95.69

1.7

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

262

374

4.62

95.42

3.3

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

268

391

4.52

95.19

1.5

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1260

4353

1.92

93.14

1.3

u/l

59.5

27.2

7.04

1100

3813

(3016650) Hepatitis A virus Ab [Presence] in Serum

1502

5501

1.81

92.71

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

510

1196

2.82

91.44

7.0

4.3

mg/l

1410.6

2961.1

0.96

402

833

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2037

8191

1.66

90.41

1.5

1.4

mg/l

562.0

520.5

0.94

1932

7832

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1478

5429

1.81

90.36

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

176

180

6.44

89.33

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

187

205

6.01

89.22

1.3

u/l

307.8

197.8

0.19

128

157

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

199

234

5.60

88.87

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

8656

45630

1.28

88.16

2.0

1.7

1.6

1.4

54.67

7560

40697

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2412

10180

1.58

87.97

3.5

u/ml

939.7

2034.7

0.84

2065

8741

(3008037) Lactate [Moles/volume] in Venous blood

1586

6006

1.75

87.55

4.5

2.6

mmol/l

1.6

0.31

1551

5887

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2399

10138

1.58

87.01

2.1

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1795

7060

1.69

86.57

1.7

1.6

e6/l

16655.1

12159.3

2.51

1334

5117

(3051611) Lipemic interference index of Serum or Plasma

944

3019

2.07

86.50

4.7

3.0

—

(3017732) Neutrophils [#/volume] in Blood

4757

23096

1.38

85.28

3.7

2.5

e9/l

4.5

4.0

28.81

3673

18219

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

183

208

5.80

84.45

4.3

4.2

mg/l

2.2

2.3

0.14

158

179

(3016038) Potassium [Moles/volume] in Urine

634

1732

2.42

84.34

1.5

1.3

mmol/l

31.7

35.1

3.07

545

1510

(42529406) Shigella sp [Presence] in Stool by Culture

2282

9606

1.58

84.12

1.3

1.1

—

(3021788) Differential panel - Synovial fluid

1438

5361

1.78

83.70

1.6

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

622

1692

2.43

83.50

1.3

1.2

u/l

110.1

82.4

5.51

565

1470

(44786800) Granulocytes/100 leukocytes in Body fluid

174

190

6.03

83.34

1.3

30.5

18.6

3.17

134

144

(3014765) Yersinia sp identified in Stool by Organism specific culture

2273

9581

1.58

83.30

1.3

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

976

3206

2.02

83.25

3.1

2.0

mmol/l

4.1

4.0

0.40

967

3185

(3035285) Chloride [Moles/volume] in Venous blood

975

3205

2.01

83.01

3.1

2.0

mmol/l

105.1

105.9

4.78

966

3183

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2254

9495

1.58

82.82

1.3

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

414

916

2.98

82.21

1.3

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1033

3480

1.97

82.14

2.6

2.0

32.1

32.8

4.95

1022

3459

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2630

11505

1.52

81.73

1.4

1.3

—

(3014271) Vancomycin [Susceptibility]

477

1154

2.73

80.86

3.2

2.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1801

7227

1.66

80.51

1.4

1.3

mmol/l

3.9

3.7

8.56

1673

6809

(3041918) Cholesterol [Moles/volume] in Pleural fluid

231

345

4.41

79.93

1.3

1.2

mmol/l

1.7

1.8

0.24

154

193

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

601

1647

2.41

79.45

1.3

1.2

u/l

34.9

19.6

6.45

539

1408

(3013005) Retinol [Moles/volume] in Serum or Plasma

523

1343

2.57

79.07

2.2

1.9

umol/l

1.9

0.02

496

1261

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

171

196

5.75

78.32

1.4

66.6

76.1

2.41

137

173

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1795

7253

1.64

78.10

1.6

1.5

e6/l

1324.8

2212.3

0.65

1491

5846

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

201

272

4.87

77.78

1.5

u/ml

56.6

57.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1463

5604

1.73

77.58

4.9

2.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1791

7250

1.64

77.37

1.6

1.4

e6/l

34.9

29.2

0.32

1416

5556

(3033705) Calcium.ionized [Moles/volume] in Venous blood

946

3161

1.98

76.99

3.2

2.0

—

(3044290) Cell count panel - Cerebral spinal fluid

1701

6812

1.66

76.61

1.6

1.4

—

(3004451) EKG impression Narrative

477

1190

2.65

76.33

1.4

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2910

13194

1.47

75.94

1.3

1.2

u/ml

1.0

0.8

0.29

256

1128

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1355

5113

1.76

75.70

1.3

1.2

u/ml

4.2

3.9

0.38

648

2266

(40761536) Microorganisms panel - Urine sediment

5626

28659

1.32

73.01

5.3

3.5

—

(3047189) Immunofixation for 24 hour Urine

436

1063

2.71

72.91

2.2

1.7

—

(3038515) Glucose [Moles/volume] in Venous blood

1452

5668

1.70

71.95

4.8

2.7

mmol/l

7.7

7.4

2.31

1426

5568

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1172

4308

1.80

71.49

1.1

g/l

1.6

1.5

8.06

1080

3894

(3042010) Triglyceride [Moles/volume] in Pleural fluid

193

275

4.62

70.58

1.3

1.2

mmol/l

0.6

2.1

2.61

122

173

(3044941) Cell count panel - Synovial fluid

1206

4510

1.77

69.48

1.5

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

318

667

3.14

69.06

2.0

1.9

u/l

44.5

34.1

0.50

291

593

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1366

5305

1.71

68.96

1.3

1.2

u/ml

4.7

3.4

0.98

486

1827

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

39366

243089

1.16

68.67

3.5

3.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

13349

75584

1.20

68.34

3.8

4.1

21.8

21.9

0.39

5777

35063

(3050129) First trimester maternal screen panel - Serum or Plasma

1397

14778

0.61

67.37

1.5

1.4

—

(40762365) Oxygen content in Arterial blood by calculation

218

361

3.98

66.51

3.0

3.1

ml/dl

14.9

14.8

0.22

206

334

(3041096) Erythrocytes [Presence] in Urine by Automated

15994

92222

1.19

66.49

4.2

2.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

802

2675

1.98

65.66

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2204

21055

0.68

65.57

1.7

1.6

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

653

2026

2.13

64.80

13.1

11.7

mmol/l

0.6

1.72

596

1872

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

646

2000

2.13

64.45

2.6

2.2

97.1

97.9

0.23

622

1847

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

168

230

4.81

64.28

3.6

2.5

mg/l

1.2

1.4

0.58

115

155

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

114

103

7.29

64.21

1.9

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1368

5421

1.67

64.12

1.1

au/ml

11.9

0.00

390

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

592

1790

2.18

62.64

1.7

1.5

u/l

7.0

6.2

0.43

336

832

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

555

1638

2.24

62.23

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

181

274

4.35

61.76

1.4

13.1

12.3

0.13

140

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5007

25681

1.31

61.28

3.4

2.4

ml/min/173m2

61.6

69.5

27.34

2188

9750

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

879

10213

0.56

61.16

1.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

296

642

3.04

60.94

11.0

7.6

—

(3032057) Clostridioides difficile [Presence] in Stool

247

479

3.40

60.62

1.9

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10875

61030

1.21

60.05

1.8

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

999

11157

0.58

59.94

1.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1595

6684

1.58

59.81

1.2

u/ml

9.8

15.7

0.46

(4198724)

582

1783

2.16

59.65

2.5

2.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

558

1684

2.19

59.34

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

975

3588

1.80

59.30

1.2

1.1

93.6

96.4

2.33

925

3350

(3023420) DNA double strand Ab [Units/volume] in Serum

957

3510

1.80

58.85

1.8

1.5

iu/ml

38.2

31.8

0.43

146

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

733

2469

1.96

58.43

1.3

1.2

mmol/l

2.2

2.0

3.57

679

2295

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

483

1391

2.29

57.37

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1243

4963

1.66

56.63

1.2

1.1

116.6

118.5

1.07

1152

4470

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

565

1752

2.13

56.22

1.2

—

(4306422)

1277

5147

1.64

56.10

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

641

2091

2.03

55.88

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

607

1942

2.06

55.73

2.1

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

299

695

2.84

54.72

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

768

2690

1.89

54.62

1.3

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

410

1122

2.41

54.56

2.6

2.3

nmol/l

148.4

151.0

0.17

359

968

(3029634) Reagin Ab [Titer] in Serum by VDRL

1260

5099

1.64

54.49

2.4

2.1

titre

7.5

6.8

0.07

150

(3048879) Bone marrow aspiration report

295

685

2.84

54.09

2.2

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

140

197

4.68

52.06

2.6

3.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1100

11591

0.62

52.00

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

434

1247

2.30

51.89

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1215

4936

1.63

51.76

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1105

11616

0.62

51.70

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1105

11609

0.62

51.57

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1379

5790

1.58

51.30

3.4

3.3

u/ml

559.3

871.6

0.84

1238

5261

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1101

11552

0.62

51.09

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

46681

294269

1.15

51.05

29.5

13.5

14.0

13.5

307.65

45973

288023

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1201

12347

0.63

50.91

1.5

—

(3049717) Cytology report of Urine Cyto stain

2293

10718

1.42

50.63

2.5

2.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

138

201

4.52

49.37

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

261

600

2.87

48.78

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

245

543

2.97

48.77

1.6

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

743

8494

0.57

48.68

1.5

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4222

21817

1.29

48.39

3.2

3.4

pmol/l

4.4

4.6

18.26

3728

19564

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1286

12866

0.65

47.99

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

439

1312

2.21

47.92

1.1

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

955

3717

1.70

47.92

1.7

1.5

60.4

54.7

4.11

617

2360

(4268621)

909

3494

1.72

47.72

2.4

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

395

1131

2.30

47.65

2.5

2.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1556

6824

1.51

47.62

1.3

1.2

u/ml

5.7

5.3

0.07

124

491

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1243

5192

1.58

47.29

1.2

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

276

669

2.72

46.89

1.1

1.2

titre

169.2

584.4

0.81

(3028707) Methadone [Presence] in Urine by Screen method

1635

7269

1.49

46.87

3.9

2.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1160

4778

1.61

46.78

1.4

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

105

125

5.53

46.55

1.1

1.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10379

59187

1.18

46.37

1.3

iu/ml

38.7

33.7

1.59

3274

18265

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

509

1639

2.05

46.05

1.7

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

225

493

3.01

45.70

2.7

2.5

mg/l

71.6

37.8

1.21

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

364

1026

2.34

45.52

3.0

2.8

umol/l

29.2

28.4

0.56

256

800

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

483

1532

2.08

45.48

1.8

1.5

iu/ml

2309165.8

1695448.5

0.38

114

(40757494) Bilirubin.total [Moles/volume] in Blood

480

1527

2.07

44.86

2.4

2.2

umol/l

39.0

47.6

0.38

151

(3038071) Oxygen [Partial pressure] in Mixed venous blood

247

578

2.82

44.78

11.0

7.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

179

344

3.43

44.69

3.4

2.9

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

952

3778

1.67

44.48

1.2

1.1

iu/ml

2.3

1.8

0.40

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1829

8409

1.44

44.18

1.3

u/ml

8.2

6.1

0.43

208

834

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1852

8537

1.44

44.11

1.3

u/ml

8.0

9.5

0.48

318

1277

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1608

7218

1.48

43.96

2.7

2.4

ug/min

141.6

102.9

2.31

991

4299

(40758047) Lysozyme [Mass/volume] in Pleural fluid

117

164

4.70

43.77

1.1

mg/l

10.7

8.5

0.97

110

148

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1982

9276

1.42

43.43

1.3

u/ml

35.1

35.4

0.02

131

539

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

102

128

5.24

42.94

6.0

4.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

220

494

2.93

42.91

3.8

2.3

mmol/l

1.2

0.13

209

475

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

208

456

3.00

42.26

3.6

2.2

mmol/l

1.2

0.59

198

435

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

533

1802

1.95

42.21

1.7

1.4

u/l

6.4

5.8

0.58

442

1523

(3020564) Creatinine [Moles/volume] in Serum or Plasma

57376

368757

1.19

41.72

27.5

12.8

umol/l

81.2

74.8

195.40

57354

368580

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

129

205

4.14

41.67

1.1

u/l

20.0

21.3

0.27

131

(3014148) Varicella zoster virus Ab [Titer] in Serum

1126

4741

1.57

41.45

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1675

7675

1.45

41.20

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

601

2138

1.86

40.91

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

150

272

3.63

40.75

1.5

ug/l

113.2

114.6

0.05

121

216

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1050

4370

1.59

40.61

2.8

u/ml

239.0

819.9

1.29

1016

4149

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

160

305

3.45

40.48

4.1

2.7

umol/l

38.4

43.5

1.81

137

262

(3005033) Fetal Nuchal fold Thickness US

903

9389

0.63

40.24

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

601

2150

1.85

40.21

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

933

9615

0.63

39.95

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

907

9403

0.63

39.90

1.4

—

(3012565) Volume of 24 hour Urine

460

1508

2.01

39.75

2.5

2.1

1871.3

2032.2

2.08

410

1356

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

717

2717

1.74

39.67

1.4

1.3

nmol/l

1.5

1.4

0.97

656

2453

(3006922) Hepatitis E virus Ab [Presence] in Serum

639

2342

1.80

39.57

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

323

920

2.31

39.55

2.2

1.9

e6/l

3188.4

3594.8

0.06

221

623

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

50128

339132

0.88

38.86

4.5

4.1

mmol/l

1.4

1.5

283.69

46457

316082

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6849

52710

0.84

38.51

2.3

2.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4841

26109

1.24

38.32

2.4

2.2

nmol/l

12.1

12.5

3.50

4258

23359

(3011544) Albumin [Mass/volume] in Pleural fluid

112

171

4.31

38.03

1.1

1.2

g/l

17.1

17.9

0.42

104

147

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

187

411

3.00

37.90

5.7

4.9

ug/min

49.3

43.9

0.50

157

311

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

188

422

2.93

36.78

1.4

1.2

—

(3025315) Body weight

124

211

3.87

36.77

5.5

3.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1473

6733

1.45

36.72

1.5

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

886

3631

1.61

36.57

1.6

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

264

711

2.45

36.56

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

7909

44881

1.18

36.56

2.6

2.4

ug/g

158.1

126.7

7.32

6404

35224

(3020393) Adenovirus Ag [Presence] in Stool

174

375

3.06

36.45

1.6

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

646

2444

1.74

36.00

2.0

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

472

1619

1.92

35.94

1.4

1.7

nmol/l

1.3

1.2

0.51

368

1285

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

320

951

2.22

35.58

1.2

1.1

—

(3022145) Colonoscopy Study observation

6676

37417

1.19

35.55

1.4

1.3

—

(3022621) pH of Urine by Test strip

3980

21178

1.25

35.51

3.4

2.7

—

(3033799) Differential panel - Peritoneal fluid

280

786

2.35

35.49

2.1

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

9651

55782

1.16

35.28

1.3

u/ml

15.6

10.5

4.28

3414

22306

(3034426) Prothrombin time (PT)

349

1079

2.13

35.24

1.2

—

(40768795) Lymph node Pathology biopsy report

742

2938

1.67

35.08

1.3

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

217

544

2.63

34.76

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

661

2547

1.71

34.56

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

660

2545

1.71

34.42

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

659

2542

1.71

34.32

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

665

2573

1.71

34.26

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

283

816

2.29

33.80

2.0

1.8

e6/l

8877.0

12385.3

0.38

146

438

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1685

8013

1.39

33.70

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

662

2570

1.70

33.70

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

50607

341506

0.88

33.69

4.5

4.1

mmol/l

4.5

4.7

268.66

47106

319583

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

662

2572

1.70

33.61

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

237

632

2.47

33.56

1.4

g/l

14.8

12.9

2.17

179

475

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

117

4.84

33.35

3.9

3.8

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

440

1515

1.92

33.18

1.2

1.1

u/l

29.8

22.7

1.68

330

1175

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

50559

323003

1.13

33.05

21.8

10.4

ml/min/173m2

82.7

85.0

79.89

43377

263001

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

113

4.89

32.98

3.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

439

1514

1.91

32.96

1.2

1.1

u/l

89.8

83.6

0.83

349

1212

(3000012) Reticulocyte production index

440

1519

1.91

32.93

1.6

1.5

—

(3023410) Appearance of Cerebral spinal fluid

822

3396

1.60

32.89

1.8

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3092

16126

1.27

32.65

2.4

—

(3003129) Base excess in Capillary blood by calculation

245

674

2.39

32.51

2.0

1.5

mmol/l

1.2

0.3

2.78

228

634

(40763480) Human metapneumovirus Ag [Presence] in Specimen

105

5.01

32.25

1.8

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

554

2071

1.76

32.23

1.6

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

997

4325

1.52

32.23

2.0

1.8

titre

2908.8

4064.8

0.39

179

(40765096) Chromosome analysis panel by Banding

264

755

2.30

32.16

1.2

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

473

1688

1.85

32.02

1.2

u/l

279.0

326.2

0.48

435

1585

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1405

12823

0.71

31.89

1.5

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6259

47788

0.85

31.48

2.2

2.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

399

1355

1.94

31.37

2.4

1.9

umol/l

27.1

28.9

2.60

384

1312

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

42384

268457

1.11

30.77

4.3

3.9

pmol/l

14.8

14.7

16.11

38977

245523

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

521

1941

1.77

30.70

1.7

1.5

u/ml

30.6

22.1

2.16

373

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

266

783

2.24

30.35

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

391

1334

1.93

30.35

2.5

umol/l

57.2

52.7

1.88

310

1128

(3016750) Collection duration of Urine

469

1700

1.82

30.26

2.5

2.1

min

498.1

501.2

0.26

330

1288

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

103

177

3.83

30.24

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3802

30267

0.81

30.12

2.1

2.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1386

6501

1.41

30.06

3.1

2.0

nmol/l

1.0

0.8

8.54

1134

5494

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

266

788

2.22

29.91

1.1

—

(3044007) Cell count panel - Peritoneal fluid

254

738

2.27

29.89

2.3

1.8

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

464

1687

1.81

29.65

1.2

1.3

titre

167.9

491.6

2.15

105

(40768804) Tissue Pathology biopsy report

22352

137276

1.11

29.63

2.2

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

254

742

2.25

29.52

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

48354

308687

1.12

29.32

6.4

5.2

mmol/mol

40.8

39.0

250.39

45049

287615

(3002523) Influenza virus A Ag [Presence] in Specimen

1274

5927

1.42

28.95

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

261

778

2.21

28.94

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.20

28.53

1.9

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

314

1014

2.04

28.45

1.3

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

901

3932

1.51

28.39

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1270

5930

1.42

28.29

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

2909

15322

1.26

28.25

4.3

3.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

693

2854

1.60

28.18

1.6

1.5

25.6

33.3

6.75

421

1797

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

449

1644

1.80

28.08

1.2

1.3

titre

76.3

76.7

0.01

146

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

441

1607

1.81

28.02

1.5

1.2

58.1

66.3

1.03

172

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

220

620

2.34

27.78

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

220

621

2.33

27.69

1.4

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

451

1665

1.79

27.47

1.8

1.5

umol/l

19.4

25.9

5.49

429

1586

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

442

1622

1.80

27.46

1.9

161.3

133.9

8.43

414

1533

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

219

620

2.33

27.39

1.4

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

259

788

2.17

27.36

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

671

2772

1.60

26.96

1.5

1.4

e6/l

138697.2

98798.3

0.69

456

1915

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

206

576

2.36

26.50

1.3

—

(3011985) Renin [Units/volume] in Plasma

980

4414

1.47

26.50

1.6

mu/l

68.9

65.0

0.22

870

3967

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

243

732

2.19

26.33

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

129

4.13

26.27

11.0

9.0

e6/l

292.8

273.4

0.04

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

184

3.54

26.17

1.6

2.0

ug/g

173.3

176.9

0.07

160

(3004775) Volume in Urine collected for unspecified duration

576

2309

1.65

26.13

2.5

2.2

706.2

674.7

0.91

389

1599

(1761482) Bacteria [#/volume] in Urine by Culture

1533

7489

1.35

26.03

5.1

3.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

176

3.59

25.87

2.7

2.1

—

(3009871) Measles virus Ab [Titer] in Serum

326

1110

1.94

25.56

1.6

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

931

4190

1.47

25.30

1.3

1.2

u/ml

56.8

50.2

0.33

257

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

51566

346416

0.90

25.28

4.9

4.5

mmol/l

2.7

2.8

246.91

47738

322283

(3002331) Protein [Mass/volume] in Peritoneal fluid

200

566

2.33

25.09

1.5

1.3

g/l

34.9

25.9

0.67

153

440

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

844

3735

1.49

24.95

2.5

1.9

mg/l

27.0

25.3

0.40

266

954

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

165

3.63

24.92

8.3

3.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

136

319

2.81

24.83

8.1

7.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2230

11559

1.28

24.73

1.5

1.4

u/l

9.6

0.11

1780

9429

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

291

2.89

24.69

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

163

422

2.54

24.69

7.6

7.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

4.91

24.56

1.1

1.2

g/l

0.1

0.42

(21491868) Cryoglobulin [Mass/volume] in Serum

309

1048

1.94

24.53

1.3

1.2

g/l

0.5

0.06

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

147

364

2.66

24.29

11.0

9.1

umol/l

0.3

0.4

0.51

133

331

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

439

1669

1.73

24.27

1.8

1.7

u/field

2.4

0.02

326

1202

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

574

2349

1.61

24.04

1.3

1.2

u/ml

11.3

9.6

0.10

169

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

523

2095

1.65

23.86

2.9

ug/l

27.7

25.6

—

(3051593) INR in Capillary blood by Coagulation assay

341

1207

1.86

23.85

8.9

9.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3042

24196

0.82

23.73

2.0

1.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

133

317

2.76

23.62

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

804

3564

1.49

23.61

1.1

au/ml

51.7

70.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

5733

43161

0.86

23.59

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

135

3.85

23.47

4.3

2.9

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

593

2462

1.59

23.42

1.3

1.2

u/ml

35.4

48.9

0.87

175

(3045414) Leukocytes [Presence] in Urine

2769

14817

1.24

23.36

2.1

1.8

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

817

3642

1.48

23.34

1.1

au/ml

26.8

22.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

131

312

2.76

23.30

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1428

7026

1.34

23.19

1.3

1.2

u/ml

44.2

42.2

0.18

163

661

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

591

2458

1.59

23.18

1.3

1.2

u/ml

79.3

64.3

0.50

108

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

393

1467

1.77

23.17

2.4

2.2

ug/l

23.2

210.7

1.79

379

1393

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

353

1276

1.82

23.13

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

603

2524

1.58

23.02

1.3

1.2

u/ml

44.8

51.8

0.18

108

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

4.79

22.78

1.1

g/l

0.2

0.06

(3036603) Volume of Urine

514

2078

1.63

22.65

1.8

1.6

1858.7

1972.0

0.63

129

441

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

573

2382

1.59

22.54

1.4

umol/l

13.5

11.6

7.92

538

2265

(3024263) Appearance of Synovial fluid

400

1518

1.74

22.30

1.7

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

13356

80811

1.11

22.20

1.3

u/ml

1.6

1.7

0.34

3411

22201

(3012898) Urea [Moles/volume] in Urine

123

292

2.77

22.04

1.5

1.7

mmol/l

157.2

175.5

0.80

111

263

(3019768) Coxiella burnetii Ab [Presence] in Serum

151

3.57

22.03

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

123

293

2.76

21.90

1.3

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.05

21.66

6.7

5.4

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

4.32

21.62

5.7

5.8

mmol/l

17.1

17.4

0.12

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

796

3588

1.46

21.55

1.4

1.3

nmol/l

19.0

33.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

122

292

2.75

21.55

1.0

1.1

—

(3002256) Pathology report gross observation

7389

43273

1.14

21.44

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

213

664

2.11

21.32

1.6

1.5

ug/l

0.4

0.28

142

437

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

567

2384

1.57

21.28

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

146

386

2.49

21.28

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

49632

318722

1.10

21.18

5.2

4.6

mu/l

2.2

2.1

0.56

45991

294757

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

617

2648

1.54

21.16

1.2

1.1

u/ml

65.9

61.0

—

(40768441) Liver Pathology biopsy report

556

2332

1.57

21.10

1.5

1.4

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

5.80

21.08

6.2

4.6

mg/l

7.4

6.2

0.18

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

219

696

2.07

20.88

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

219

696

2.07

20.88

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

219

696

2.07

20.88

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

219

696

2.07

20.88

1.1

—

(3002619) Bacteria identified in Specimen by Culture

200

614

2.14

20.82

1.3

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

59221

393907

0.87

20.82

35.9

16.7

g/l

132.3

136.7

307.65

58609

388743

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

120

3.84

20.76

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

632

2744

1.52

20.57

3.1

3.0

mg/l

92.3

45.9

2.21

469

1939

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.46

20.37

1.4

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

538

2261

1.57

20.27

1.7

1.4

umol/l

69.5

70.1

0.07

188

(40768443) Skin Pathology biopsy report

2642

14286

1.22

20.20

1.2

—

(3010813) Leukocytes [#/volume] in Blood

59225

393844

0.87

20.03

35.8

16.6

e9/l

7.3

6.6

307.65

57991

382562

(3032352) Blasts [#/volume] in Cerebral spinal fluid

122

304

2.64

20.02

2.3

2.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

175

3.23

19.99

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

582

2498

1.54

19.99

1.3

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

59214

393765

0.87

19.93

35.7

16.6

e12/l

4.4

4.5

307.65

57991

382466

(3035320) C reactive protein [Mass/volume] in Body fluid

548

2324

1.55

19.86

3.2

2.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

324

1198

1.78

19.82

1.9

190.5

153.4

6.24

311

1127

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

127

325

2.57

19.80

1.2

1.5

—

(3024731) MCV [Entitic volume]

59210

393725

0.87

19.80

35.6

16.5

90.9

90.6

66.18

58602

388486

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

9248

55157

1.12

19.76

2.7

2.9

ug/l

0.7

0.8

1.09

6032

34950

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

769

3504

1.45

19.73

3.2

nmol/l

7.2

6.9

0.07

743

3395

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

649

2865

1.49

19.55

4.5

3.6

u/ml

58.7

45.1

0.92

644

2830

(3035941) MCH [Entitic mass]

59207

393678

0.87

19.55

35.5

16.5

30.2

7.01

58597

388456

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

558

2385

1.54

19.54

2.1

1.9

u/field

2.0

2.4

0.96

280

1047

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1720

14237

0.79

19.40

1.9

1.6

mg/l

5.6

3.2

8.25

1333

9746

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

613

5919

0.68

19.30

1.3

ug/l

3.3

3.7

1.30

532

5335

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

548

5401

0.66

19.18

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

403

1604

1.66

18.98

6.9

5.8

u/ml

122.3

3832.1

1.07

103

304

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

145

405

2.36

18.88

2.4

2.5

mmol/l

1.0

1.5

1.47

296

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

208

675

2.03

18.82

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

157

456

2.27

18.72

1.2

1.1

pmol/l

4.0

7.0

0.36

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

873

4112

1.40

18.68

1.3

1.4

pmol/l

308.3

307.5

0.01

672

3220

(36660697) Celiac disease serology panel - Serum

5023

28921

1.15

18.56

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

360

1401

1.69

18.46

2.1

ug/min

102.9

96.0

0.09

307

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2653

14500

1.21

18.24

1.1

u/ml

15.1

9.3

0.25

223

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

531

2285

1.53

18.08

1.1

iu/ml

9.3

7.8

0.60

116

598

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.80

17.87

10.5

6.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

214

718

1.96

17.70

1.1

1.2

90.2

86.9

0.39

168

(3007461) Platelets [#/volume] in Blood

59188

393338

0.88

17.67

35.7

16.6

e9/l

255.6

253.4

11.09

58114

383092

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

213

716

1.96

17.53

1.1

1.2

76.8

75.0

0.19

162

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

140

400

2.30

17.38

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

282

3155

0.59

17.34

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

368

1467

1.65

17.28

1.6

1.4

3.1

4.7

1.45

314

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

48758

327072

0.92

17.12

4.1

3.7

mmol/l

1.4

1.3

160.12

44930

303378

(3001686) Cold agglutinin [Titer] in Serum or Plasma

160

488

2.16

17.04

1.4

1.3

titre

42.8

174.5

1.41

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.52

16.71

1.1

1.2

ng/l

3792.9

2727.2

0.25

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

303

1158

1.72

16.65

2.9

2.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

299

1140

1.73

16.57

1.1

87.9

92.6

0.98

158

518

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

145

430

2.22

16.54

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

4.59

16.31

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

153

3.14

16.29

1.2

1.1

u/field

1.2

1.3

0.27

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.81

16.23

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

308

1192

1.70

16.20

1.2

103.8

109.2

1.34

286

1069

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

699

3252

1.42

16.13

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

942

4605

1.35

16.12

1.3

nmol/l

1.5

1.2

0.12

887

4458

(3045424) Erythrocytes [Presence] in Urine

1123

5636

1.32

16.06

1.6

1.4

—

(46236302) HLA-C [Type] by High resolution typing

3.72

16.03

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

662

3055

1.43

15.99

2.2

2.3

nmol/l

19.0

19.7

0.65

617

2912

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

143

428

2.20

15.98

1.2

1.5

nmol/l

105316.7

239894.7

0.64

113

356

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

303

1172

1.70

15.98

1.1

88.2

91.6

0.94

159

529

(3016244) Insulin [Units/volume] in Serum or Plasma

550

2451

1.48

15.94

3.4

3.2

mu/l

25.1

27.5

0.71

513

2299

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.23

15.86

3.4

3.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

937

4589

1.35

15.85

1.3

nmol/l

0.2

0.02

268

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

103

3.64

15.84

1.9

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2265

12364

1.21

15.80

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

231

829

1.83

15.70

2.1

1.6

—

(40758292) HTLV I+II Ab panel - Serum

164

523

2.06

15.65

1.5

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

266

998

1.76

15.63

1.3

1.2

27.3

18.1

1.03

165

(40760409) HLA-A [Type] by High resolution

3.69

15.59

1.0

—

(40760410) HLA-B [Type] by High resolution

3.69

15.59

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.59

15.43

4.0

3.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

147

452

2.14

15.40

1.5

1.6

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

214

757

1.86

15.23

1.3

107.9

106.3

0.25

203

714

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1428

7449

1.27

15.18

1.9

pmol/l

192.5

196.7

0.72

1347

7099

(3013862) HLA-DP [Type]

100

3.62

15.17

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

122

352

2.28

14.89

2.5

—

(40763590) HLA-DQ beta [Type]

3.59

14.74

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.11

14.67

1.1

mmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

850

4160

1.35

14.50

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

147

465

2.08

14.37

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

138

3.10

14.26

20.5

9.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

281

1103

1.68

14.11

1.3

1.1

—

(3020491) Glucose [Moles/volume] in Blood

543

2475

1.45

14.09

2.1

1.6

mmol/l

7.3

6.5

5.22

409

1825

(3036670) Protein [Mass/volume] in Synovial fluid

225

830

1.78

14.06

1.3

1.2

g/l

38.7

40.6

1.07

131

438

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

135

417

2.13

14.04

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

263

2.45

14.04

1.2

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

980

4922

1.31

14.01

4.4

3.4

u/ml

45.5

35.7

0.91

951

4733

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

4.10

13.99

5.5

5.7

mg/l

1.1

1.5

0.50

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

178

610

1.92

13.98

1.3

1.2

mg/l

70.0

41.8

0.29

130

440

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

740

3569

1.37

13.89

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

164

549

1.97

13.79

4.3

6.5

65.1

71.7

1.93

115

451

(40761511) CBC panel - Blood by Automated count

56371

365711

1.10

13.72

22.2

10.6

—

(3011288) Drugs identified in Urine by Screen method

2148

11838

1.20

13.59

4.7

2.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

198

711

1.83

13.52

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

344

3461

0.65

13.50

1.6

mmol/l

7.8

7.6

0.93

218

2038

(3011335) Digoxin [Mass/volume] in Serum or Plasma

168

2.82

13.50

2.3

2.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

265

2.41

13.41

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

195

2.66

13.37

1.2

ug/l

98.2

110.8

0.34

121

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.73

13.30

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.23

13.21

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2439

13636

1.18

13.13

3.3

2.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

136

433

2.07

13.13

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

1376

7277

1.25

13.07

2.4

2.0

—

(40763791) Oxygen content in Venous blood by calculation

3.95

13.05

5.0

8.4

ml/dl

12.0

12.9

0.68

(3005570) Glucose [Moles/volume] in Urine

655

3139

1.38

12.83

2.1

1.8

mmol/l

10.4

21.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

138

446

2.04

12.82

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

251

2.41

12.78

1.3

1.4

ml/s/173m2

1.0

1.8

1.59

161

(3051387) C reactive protein [Mass/volume] in Capillary blood

1303

6869

1.25

12.74

4.6

3.0

mg/l

32.3

24.7

9.46

910

4149

(3029075) Extractable nuclear Ab panel - Serum

254

1003

1.67

12.54

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1581

8535

1.22

12.42

1.8

1.9

iu/l

56.3

12.2

0.55

504

3244

(3042517) Benzodiazepines panel - Urine

140

461

2.00

12.38

2.6

3.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

355

1527

1.53

12.32

1.6

mmol/24h

5.9

5.5

0.14

122

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

131

422

2.04

12.30

1.4

1.1

mmol/l

21.2

20.2

1.78

105

363

(3019897) Erythrocyte distribution width [Ratio] by Automated count

618

5499

0.74

12.19

4.1

2.3

13.3

13.1

4.63

611

5429

(3010015) Selenium [Moles/volume] in Serum or Plasma

101

294

2.26

12.18

2.3

2.1

umol/l

1.2

1.3

1.18

264

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

4.12

12.17

11.8

6.3

41.3

44.9

0.25

(3030313) Adrenal Ab [Titer] in Serum

109

328

2.19

12.16

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

379

1659

1.50

12.13

1.1

1.2

u/ml

16.3

11.6

0.26

160

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5708

41308

0.90

12.09

1.7

1.8

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

195

723

1.78

12.06

1.2

pmol/l

370.2

314.3

0.27

137

542

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

238

2.40

12.04

1.3

1.4

pmol/l

15.1

11.7

0.51

202

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

158

550

1.89

11.94

2.5

2.4

mmol/l

7.9

7.3

0.91

100

327

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

500

2320

1.42

11.88

1.2

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

216

829

1.72

11.87

1.5

1.3

umol/l

17.2

16.8

0.55

192

744

(4212803)

220

2.45

11.83

1.1

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

5.51

11.69

1.5

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

57115

371173

1.09

11.64

15.0

9.0

u/l

27.5

26.6

9.15

55741

358527

(3035933) Granulocytes/100 leukocytes in Blood

251

1010

1.64

11.58

2.6

1.6

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

220

2.42

11.41

2.5

2.1

58.2

57.8

0.03

135

(3022229) Phosphate [Moles/volume] in Urine

220

2.42

11.41

1.8

2.5

mmol/l

20.2

20.5

0.04

191

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.50

11.14

1.1

—

(3007463) Buprenorphine [Presence] in Urine

145

2.77

11.14

9.3

7.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

310

1325

1.54

11.13

1.1

ng/l

637.5

523.4

0.16

286

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

100

304

2.16

10.94

2.1

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3283

19060

1.14

10.74

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

166

611

1.79

10.59

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

2.73

10.56

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1039

5459

1.26

10.55

1.1

iu/ml

46.2

2570.9

0.80

221

1259

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.02

10.55

1.2

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

196

759

1.70

10.50

1.6

1.3

33.8

41.3

1.90

135

507

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

500

2376

1.39

10.43

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

497

2360

1.39

10.41

1.3

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

541

2606

1.37

10.39

1.1

mg/l

296.1

402.3

0.46

492

2339

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3713

21774

1.13

10.37

1.3

au/ml

35.5

50.4

3.42

107

914

(3009992) Blasts/100 cells in Bone marrow

7.98

10.33

1.8

1.7

11.6

24.5

0.69

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

364

1641

1.46

10.17

1.1

miu/ml

1511.5

1519.8

0.05

364

1641

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

121

408

1.95

10.12

1.8

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

348

1563

1.47

9.93

1.7

1.6

nmol/l

3.9

8.4

0.62

296

1293

(3045462) Protein/Creatinine [Ratio] in Urine

114

380

1.97

9.86

5.4

5.5

g/mol

42.3

207.1

0.71

108

349

(3005082) Progesterone [Moles/volume] in Serum or Plasma

229

2334

0.64

9.73

1.3

1.4

nmol/l

29.7

31.6

0.50

200

2149

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

886

0.43

9.71

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

466

2224

1.38

9.52

1.2

1.1

ratio

1.1

1.90

151

796

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5756

41133

0.91

9.36

1.5

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

204

825

1.63

9.34

1.3

nmol/l

138.5

126.4

0.41

142

621

(3028717) Thiamine [Mass/volume] in Blood

316

2.04

9.31

1.1

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

121

422

1.89

9.22

1.2

1.4

41.8

54.8

1.91

207

(3018133) Calcium [Moles/volume] in Urine

159

604

1.73

9.19

2.2

2.3

mmol/l

2.5

2.7

0.56

144

547

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4013

23841

1.11

8.96

2.4

au/ml

23.6

23.3

0.05

166

1529

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

209

2.27

8.87

1.1

iu/ml

17.5

16.3

0.06

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

443

2126

1.37

8.80

3.4

3.2

nmol/l

151.8

120.4

1.02

431

2089

(3021162) Amylase [Enzymatic activity/volume] in Specimen

127

458

1.82

8.75

2.4

2.9

u/l

2021.3

1709.6

0.16

107

416

(3041806) Other cells [#/volume] in Blood by Manual count

170

1805

0.62

8.74

1.6

1.4

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

6.21

8.52

1.1

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

158

614

1.69

8.47

1.5

1.6

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

152

2.47

8.46

1.2

1.4

u/l

1593.4

825.4

0.26

132

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

121

2.66

8.45

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1320

7282

1.20

8.44

1.8

1.7

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

146

556

1.73

8.42

4.5

4.8

u/l

49.8

57.6

0.31

214

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.86

8.41

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1913

10891

1.16

8.35

1.8

1.7

nmol/l

39.1

41.0

2.86

1868

10652

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

316

1.98

8.34

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

141

533

1.74

8.34

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

401

1911

1.38

8.34

1.6

1.5

ug/l

10.1

7.5

0.94

358

1738

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

276

2.05

8.32

1.1

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.16

8.29

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

264

2.07

8.23

1.1

1.0

u/ml

8.2

2.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2258

13024

1.14

8.22

1.7

1.6

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.01

8.13

1.1

1.0

mmol/l

5.8

5.0

0.55

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

205

2.21

8.10

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

13877

87040

1.06

8.03

1.7

1.6

mmol/l

1.5

1.4

44.34

11910

73564

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

105

367

1.88

8.02

2.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

549

2762

1.31

8.00

1.1

—

(4034850)

1860

10606

1.16

7.97

12.6

8.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

396

1905

1.37

7.81

1.1

nmol/l

4.7

5.0

0.06

353

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

162

650

1.64

7.75

2.2

2.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

281

1275

1.45

7.74

2.2

2.7

ug/l

1.1

1.2

0.37

263

1203

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

289

1.98

7.71

1.3

1.2

mg/l

48.8

47.1

0.11

(37021550) Renin [Units/volume] in Plasma --upright

163

656

1.63

7.71

1.3

mu/l

142.6

64.0

0.97

121

496

(3026657) Rickettsia conorii Ab [Titer] in Serum

3.62

7.62

1.0

1.1

—

358.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.62

7.62

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

257

1150

1.47

7.61

1.1

—

(44806071)

120

450

1.75

7.36

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.74

7.35

1.3

1.4

u/field

0.7

0.05

(4024509)

566

2895

1.29

7.34

1.6

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

143

2.39

7.29

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

264

1207

1.44

7.04

1.3

1.4

pmol/l

16.4

14.4

1.86

226

1015

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

176

740

1.56

7.00

1.4

1.2

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

134

2.40

6.97

1.0

1.1

21.0

21.5

0.32

123

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

134

2.40

6.97

1.0

1.1

36.4

35.9

0.24

125

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

134

2.40

6.97

1.0

9.0

8.8

0.15

124

(3013166) Neutrophils/100 leukocytes in Synovial fluid

209

916

1.50

6.90

1.4

60.0

52.8

1.99

173

790

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

4.24

6.89

1.2

1.0

—

(3006270) Folate [Moles/volume] in Blood

512

2609

1.29

6.87

1.2

1.1

nmol/l

342.1

378.1

3.05

419

2245

(3019174) dRVVT (LA screen)

298

1.90

6.81

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

105

2.57

6.67

1.1

u/field

1.0

1.3

0.62

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

121

2.45

6.65

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

201

2.09

6.64

1.4

1.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

171

2.19

6.62

1.1

u/l

2.6

3.1

0.23

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

198

2.09

6.53

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

178

2.14

6.39

1.3

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

110

422

1.71

6.31

1.1

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

179

2.13

6.31

2.7

2.1

12.9

17.9

0.57

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

229

1043

1.44

6.29

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

369

1.76

6.27

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

198

2.06

6.19

1.3

1.6

12.9

12.7

0.02

142

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

253

1180

1.41

6.12

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

147

2.24

6.12

1.2

1.3

u/ml

29.9

16.9

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

217

2.00

6.11

1.0

1.2

28.2

19.0

0.43

(3044009) aPTT.lupus sensitive (LA screen)

315

1.82

6.07

1.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

227

1.97

6.04

1.3

1.5

46.0

34.9

1.28

151

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.71

5.99

1.6

1.5

nmol/l

376.2

183.8

0.93

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

179

2.09

5.96

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

167

2.13

5.87

1.2

1.4

2.6

1.1

1.04

109

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

377

1.73

5.86

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

129

2.29

5.84

4.0

2.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

203

2.01

5.82

4.3

4.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

564

2974

1.25

5.80

1.2

1.1

mg/l

47.0

41.7

0.61

478

2477

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

326

1606

1.34

5.67

1.1

97.2

97.5

0.04

275

1268

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

544

2867

1.25

5.64

1.1

mg/l

287.9

258.1

0.97

481

2515

(3028679) Herpes simplex virus Ab [Presence] in Serum

397

2013

1.30

5.63

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

154

664

1.53

5.59

1.1

umol/24h

1.1

2.9

0.38

325

(3018738) Hemoglobin F/Hemoglobin.total in Blood

262

1.86

5.58

5.5

2.4

13.2

9.4

0.74

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

664

5290

0.82

5.56

1.3

mmol/l

7.3

7.0

1.35

491

3771

(3028468) Fragments [Presence] in Blood by Light microscopy

5.63

5.53

2.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

263

1259

1.37

5.51

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

370

1865

1.31

5.50

1.0

ng/l

264.5

343.7

3.12

265

1339

(3035611) Eosinophils/100 leukocytes in Synovial fluid

181

2.03

5.47

1.6

1.7

0.7

0.8

0.07

141

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

11635

73347

1.05

5.37

1.7

1.6

—

(4146454)

606

3252

1.23

5.35

2.7

2.8

—

(3024316) Viscosity of Plasma

139

2.18

5.33

2.1

1.7

mpas

1.6

1.7

0.56

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

276

1340

1.36

5.31

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2667

19220

0.91

5.26

1.5

1.3

iu/l

24.2

26.7

3.90

2230

16533

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

6.57

5.23

1.1

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

6.57

5.23

1.1

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

235

1.87

5.22

1.3

1.2

—

(3001729) Color of Synovial fluid

217

1.91

5.18

1.5

1.6

—

(3016879) Cocaine [Presence] in Urine

2748

16498

1.10

5.12

3.2

2.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

369

1879

1.29

5.12

1.0

ng/l

747.6

750.3

0.04

250

1306

(4027681)

441

2300

1.26

5.06

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

369

1883

1.29

5.04

1.0

ng/l

40.0

42.0

0.14

255

1332

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

802

6222

0.85

5.04

1.5

1.4

nmol/l

0.4

0.92

605

4941

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

118

2.23

4.93

9.7

8.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

806

6237

0.85

4.92

1.5

1.6

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

387

1.65

4.92

3.5

3.0

mg/l

18.9

24.0

3.80

366

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

379

1.65

4.83

3.5

3.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

181

1.96

4.83

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

154

2.05

4.83

1.1

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.01

4.82

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

117

492

1.56

4.81

1.7

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

271

1.77

4.79

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

3.07

4.74

5.8

7.2

e6/l

6223.7

450.8

0.44

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6373

39657

1.06

4.68

10.6

5.9

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

117

2.19

4.64

1.2

1.3

u/field

1.0

1.2

0.44

(3022689) Creatine [Moles/volume] in Urine

193

907

1.40

4.60

1.7

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

235

1142

1.35

4.57

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

243

1188

1.35

4.55

1.3

1.2

112.3

110.9

0.30

214

1067

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

215

1033

1.37

4.50

1.7

au/ml

107.7

140.6

0.55

140

(3025130) Human papilloma virus identified in Specimen

690

5357

0.84

4.44

1.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

261

1296

1.33

4.41

2.1

2.0

mg/l

8.3

9.5

2.76

215

1034

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

250

1234

1.33

4.41

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

4.82

4.37

1.1

1.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

3.65

4.35

1.1

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

212

1.83

4.34

1.3

1.5

umol/24h

347.4

317.0

0.38

212

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

205

1818

0.74

4.30

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

117

2.14

4.28

1.3

1.4

nmol/l

649.6

443.6

1.11

117

(3007916) DNA double strand Ab [Titer] in Serum

408

1.58

4.26

1.6

1.3

titre

213.3

123.8

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

178

1.88

4.12

1.1

u/l

70.7

87.6

0.14

143

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

202

1.82

4.09

1.4

1.3

pmol/l

15.3

17.6

0.54

174

(3009015) Lactate [Moles/volume] in Synovial fluid

300

1.67

4.09

1.2

1.3

mmol/l

6.2

6.0

0.11

145

(37019676) Renin [Units/volume] in Plasma --supine

2.59

4.08

1.0

1.1

mu/l

80.2

48.0

0.32

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

321

0.41

4.06

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

377

1988

1.25

4.03

1.1

u/l

1.1

0.60

157

902

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

317

1639

1.27

4.01

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1084

8076

0.88

4.01

1.5

1.4

pmol/l

141.6

123.0

0.65

1055

7871

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

420

2244

1.23

3.99

2.1

1.9

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

142

650

1.44

3.98

1.5

nmol/l

0.2

1.82

107

469

(3034092) Cytoplasmic Ig cells/100 cells in Blood

104

447

1.53

3.96

13.6

6.0

—

(3009677) Dengue virus Ab [Presence] in Serum

130

2.02

3.95

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

220

1.76

3.89

1.1

u/l

11.6

9.5

0.45

220

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

4.70

3.87

1.0

1.1

—

(36303858) Crystals [Presence] in Urine

2.96

3.87

1.1

1.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

2.41

3.85

2.1

1.6

umol/l

270.3

294.1

0.09

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.41

3.85

1.7

1.5

nmol/l

443.3

211.0

0.77

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

142

655

1.43

3.83

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

385

1.55

3.74

2.5

2.3

u/field

0.6

0.13

385

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

733

5577

0.86

3.72

1.5

—

(3000285) Sodium [Moles/volume] in Blood

365

1.57

3.71

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

163

777

1.38

3.67

1.1

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

388

1.54

3.63

1.7

mg/l

1.7

0.02

328

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

3.18

3.61

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

116

522

1.46

3.59

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

104

2.09

3.56

1.3

1.1

nmol/l

311.9

251.7

0.60

104

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.19

3.52

1.4

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.56

3.52

1.0

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.36

3.42

1.7

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

251

1291

1.28

3.39

1.3

1.2

g/l

0.3

1.23

199

1024

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

322

1.57

3.37

1.1

umol/24h

1.9

2.8

0.35

322

(3051339) Copper [Moles/volume] in Blood

167

1.81

3.36

1.3

umol/l

16.2

16.7

0.27

144

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

130

1.92

3.32

1.0

u/ml

0.1

0.24

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

278

1.61

3.28

1.3

1.2

nmol/l

17.4

15.9

0.24

(3049233) Organic acids panel - Urine

2.25

3.25

1.2

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.25

3.25

1.2

1.3

mmol/l

3.5

3.1

0.30

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

150

1.84

3.24

1.2

1.3

—

14622.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

7.67

3.24

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

147

1.83

3.14

1.0

u/ml

0.1

0.2

0.65

(3010370) Gastrin [Moles/volume] in Serum or Plasma

112

518

1.42

3.07

1.6

1.8

pmol/l

44.4

57.5

0.58

431

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

102

2.00

3.04

1.1

pmol/l

185.5

220.7

0.19

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

186

937

1.31

2.99

1.6

ug/l

9.8

9.0

1.39

186

937

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2460

17333

0.93

2.99

2.5

2.3

u/l

5461.8

6175.3

0.51

865

6859

(3000764) Benzodiazepines [Presence] in Urine

2882

17765

1.07

2.95

3.1

2.0

—

(3041184) Isoniazid [Presence] in Urine

2.88

2.91

2.9

2.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

192

1.68

2.82

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

233

1.61

2.80

1.3

1.4

umol/l

91.4

80.6

0.96

215

(3020123) Porphyrins [Interpretation] in Serum or Plasma

198

1.66

2.78

1.1

—

(3032641) Amino acids panel - Urine

2.31

2.77

1.5

1.2

—

(3043614) Bacteria identified in Aspirate by Culture

5.75

2.77

1.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

4.78

2.75

1.1

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.78

2.75

1.1

1.2

—

(3027874) Urate [Moles/volume] in Urine

1.97

2.75

1.1

1.0

mmol/l

1.9

8.2

0.48

(3028300) Cannabinoids [Presence] in Urine

2899

17932

1.07

2.70

3.1

2.0

—

(3027008) Opiates [Presence] in Urine

2890

17886

1.06

2.65

3.1

2.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.37

2.64

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

168

856

1.29

2.54

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.63

2.52

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

100

472

1.39

2.51

2.0

1.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

304

2395

0.83

2.51

1.2

1.3

g/l

1.4

1.5

0.51

133

(3009542) Hematocrit [Volume Fraction] of Blood

50221

327867

1.03

2.49

25.9

12.0

39.2

40.2

117.44

35912

249096

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

279

1512

1.21

2.48

3.1

3.3

mg/l

8.0

8.1

0.12

221

1216

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

268

1448

1.22

2.46

1.2

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

211

1.59

2.43

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

256

1379

1.22

2.43

2.6

2.7

au/ml

140.7

150.8

0.11

184

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.94

2.41

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.16

2.41

1.5

1.2

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

5.63

2.40

1.0

—

(3022670) pH of Venous cord blood

107

1.84

2.40

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

167

858

1.28

2.40

1.6

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

113

1.80

2.33

1.8

2.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

159

816

1.28

2.32

1.1

mg/g

7.3

6.8

0.36

147

777

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

272

1.50

2.31

1.4

u/ml

6.3

6.7

0.03

230

(4094501)

1261

9007

0.92

2.26

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.01

2.25

1.5

1.6

ug/l

139.7

126.9

0.08

(3020399) Glucose [Mass/volume] in Urine

6.57

2.25

1.8

1.2

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

6.57

2.25

1.6

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

317

1.45

2.24

1.0

kpa

3.5

3.6

0.08

273

(3025577) Chromium [Mass/volume] in Blood

306

1695

1.19

2.20

2.0

2.1

ug/l

2.4

2.3

0.00

248

1431

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.42

2.18

2.9

2.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1708

10475

1.07

2.13

1.1

u/ml

7.3

5.2

0.71

160

1456

(3015183) Erythrocyte sedimentation rate

251

1976

0.83

2.12

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

305

1700

1.18

2.07

1.1

u/ml

9.2

9.9

0.13

292

(3004959) Base excess in Arterial cord blood by calculation

323

1.42

2.06

1.0

mmol/l

-1.1

-2.3

0.68

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

4.38

2.04

2.8

1.8

—

(3026470) Cobalt [Mass/volume] in Blood

312

1746

1.18

2.02

1.9

2.0

ug/l

3.6

3.7

0.06

276

1536

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

325

1.42

2.00

1.0

kpa

7.3

7.2

0.21

283

(44813793)

468

2702

1.14

2.00

1.1

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

2.30

1.98

4.5

2.6

nmol/l

327.8

367.0

—

(3006598) pH of Arterial cord blood

326

1.41

1.97

1.0

—

(3027944) Amphetamines [Presence] in Urine

2816

17608

1.05

1.91

2.9

1.9

—

(3018291) Platelet Ab [Presence] in Serum

2.07

1.90

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

252

1.46

1.90

1.1

u/ml

40.0

31.6

0.20

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

252

1.46

1.90

1.1

u/ml

24.5

24.4

0.01

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2908

20051

0.95

1.86

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

432

1.34

1.83

2.7

2.6

pmol/l

70.1

69.1

0.02

373

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

481

0.70

1.79

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

990

6002

1.09

1.73

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.89

1.70

1.2

1.0

g/l

0.5

0.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

3.29

1.62

1.0

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

308

2323

0.87

1.61

2.3

1.9

—

(3049242) von Willebrand panel - Platelet poor plasma

102

1.68

1.61

1.6

—

(3013762) Body weight Measured

128

1.59

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

269

1.39

1.56

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.89

1.55

1.1

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

209

1.45

1.54

1.5

1.4

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.26

1.53

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.03

1.51

1.2

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.75

1.51

1.0

1.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.91

1.50

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

162

1.50

1.49

1.5

1.7

ng/l

191.5

201.9

0.30

141

(3003694) ABO and Rh group [Type] in Blood

15749

101883

1.02

1.48

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

152

0.52

1.46

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

227

0.61

1.46

1.2

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.73

1.45

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.37

1.43

1.1

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.83

1.42

1.1

1.0

g/l

0.0

0.1

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

2.82

1.40

3.8

5.7

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.68

1.40

1.0

—

(4133840)

179

993

1.19

1.39

1.3

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

2.08

1.39

1.1

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

2.08

1.39

1.1

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

242

1.39

1.38

1.0

1.1

u/ml

1.1

1.6

0.30

179

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6179

39552

1.03

1.37

4.5

4.2

31.7

32.2

2.50

4550

27523

(3027305) Fractional oxyhemoglobin in Arterial cord blood

1.92

1.34

1.1

1.0

42.3

31.1

0.98

(3006462) Nitrate [Presence] in Urine

279

1611

1.14

1.31

3.3

2.9

—

(40768793) Breast Pathology biopsy report

1061

7439

0.94

1.31

1.3

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

2.63

1.31

1.0

1.1

—

(3013931) Oligosaccharides [Presence] in Urine

2.63

1.31

1.2

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

2.63

1.31

1.0

1.1

—

(3003338) MCHC [Mass/volume]

46273

305694

0.98

1.23

31.1

14.2

g/l

331.4

333.1

241.75

45893

303451

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

492

1.24

1.21

2.2

2.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

418

3029

0.91

1.19

1.4

1.3

pmol/l

89.1

110.5

0.29

187

904

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1105

6842

1.06

1.18

1.1

u/ml

2.6

2.3

0.26

309

1729

(1617658) Protocol used for examination of sentinel lymph nodes

330

2416

0.90

1.16

1.0

—

(3034614) HLA Ag [Interpretation]

1.62

1.10

1.6

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

522

1.22

1.10

1.1

u/ml

0.2

0.3

0.20

315

(4281824)

563

3418

1.08

1.2

1.1

—

(3036180) Methadone [Presence] in Urine

1.58

1.07

1.6

3.1

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

110

1.49

1.05

1.0

u/ml

0.0

0.3

1.56

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

209

1208

1.14

1.03

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2323

14714

1.04

1.03

1.7

1.6

mu/l

330.4

309.8

1.43

2088

13288

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

222

1.33

1.02

1.0

u/ml

0.9

0.5

0.36

200

(4211845)

300

1775

1.11

1.01

3.2

2.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

244

1799

0.89

1.01

1.8

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

410

2466

1.09

1.00

1.2

—

(40768800) Prostate Pathology biopsy report

817

5711

0.94

0.99

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

203

1510

0.88

0.98

1.8

1.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

257

0.72

0.96

1.0

—

(40762814) Titanium [Mass/volume] in Blood

484

1.21

0.95

2.3

ug/l

3.7

0.00

172

(40765089) Chromosome analysis panel - Blood by G-banded

184

1372

0.88

0.94

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

568

3475

1.08

0.93

1.3

1.4

mmol/l

12.1

11.8

0.29

212

739

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.81

0.92

1.0

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.08

0.88

1.0

1.1

umol/l

11.8

17.7

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.88

0.88

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1290

8108

1.05

0.87

1.2

1.1

u/ml

2.2

1.7

0.69

624

3336

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.76

0.86

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.76

0.86

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.76

0.86

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.76

0.86

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.76

0.86

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.76

0.86

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

331

1.23

0.82

1.7

1.6

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.56

0.80

1.4

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

130

1.37

0.76

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

102

1.42

0.76

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1107

6962

1.05

0.76

1.1

u/ml

1.1

0.05

552

3001

(3033942) Copper [Moles/time] in 24 hour Urine

165

1.31

0.74

1.4

1.2

umol/24h

1.2

0.8

0.23

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.64

0.71

1.1

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

1.93

0.70

1.0

1.1

umol/l

62.0

21.4

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

132

766

1.13

0.69

1.2

1.1

u/ml

7.4

7.1

0.03

545

(3013139) Helicobacter pylori Ag [Presence] in Stool

3473

23351

0.98

0.69

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

150

1.31

0.68

1.6

1.5

u/l

0.2

0.12

(3003888) Timothy IgE Ab [Units/volume] in Serum

1160

7326

1.04

0.68

1.1

u/ml

6.1

5.6

0.35

680

3821

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.39

0.68

1.1

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

522

1.16

0.67

1.1

1.0

ug/l

77.5

82.3

0.47

436

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.64

0.67

3.7

3.9

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

239

1.24

0.66

2.5

2.9

pmol/l

1206.6

80.5

0.46

(3029396) Erythrocyte agglutination [Presence] in Blood

164

1197

0.90

0.65

2.8

3.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

948

5970

1.04

0.65

1.3

1.4

u/l

24.6

25.1

0.20

785

4930

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

216

1.25

0.65

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

228

1.24

0.64

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

353

2163

1.07

0.64

1.4

1.3

umol/l

4.5

5.1

2.74

320

1996

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

0.7

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.44

0.62

1.4

nmol/l

164.7

131.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

182

1.26

0.62

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.57

0.61

1.0

1.1

titre

1110.9

2221.3

1.15

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

198

1188

1.10

0.60

1.1

1.0

u/ml

9.1

11.3

0.41

157

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

142

1.30

0.60

1.2

1.1

u/l

285.3

355.5

0.25

123

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

50294

329725

1.01

0.59

4.8

4.2

mmol/l

6.1

5.8

191.10

46241

303893

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1987

12716

1.03

0.58

1.3

miu/ml

213.1

225.9

0.75

720

6130

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

597

0.87

0.57

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

463

0.85

0.57

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

440

1.15

0.55

1.1

u/ml

2.1

5.1

1.01

341

(3051101) Glucose [Moles/volume] in Cord blood

502

1.14

0.54

5.2

5.8

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.58

0.54

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

211

1.22

0.52

1.2

1.1

—

(44806420)

130

773

1.11

0.50

2.1

2.4

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

420

1.14

0.49

1.0

u/ml

0.2

0.02

255

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

107

631

1.11

0.49

1.5

nmol/l

5.0

6.2

1.00

100

603

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

768

4857

1.04

0.49

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

439

1.14

0.48

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.37

0.47

1.5

1.4

mmol/24h

1.7

2.1

0.67

(3025966) Peach IgE Ab [Units/volume] in Serum

1.44

0.46

1.1

1.0

u/ml

2.7

3.4

—

(3003577) Lead [Moles/volume] in Blood

275

1.17

0.46

1.4

umol/l

0.3

0.2

0.28

(3034274) Bile acid [Moles/volume] in Serum --fasting

818

5571

0.96

0.46

2.2

umol/l

6.3

7.0

0.60

620

4067

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

443

1.13

0.44

1.1

u/ml

3.2

2.9

0.06

339

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.42

0.0

1.0

—

(3002480) Lead [Moles/volume] in Urine

0.00

0.42

0.0

1.0

—

0.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

1.57

0.42

1.0

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.57

0.42

1.4

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

1.57

0.42

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.42

0.0

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3855

25704

0.98

0.40

1.2

iu/ml

124.3

143.9

2.41

1343

9816

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.27

0.39

1.3

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.31

0.37

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

300

1.14

0.37

1.0

u/ml

2.0

1.3

0.27

204

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

338

1.13

0.36

1.0

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.40

0.36

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

301

1.14

0.35

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2772

17945

1.02

0.35

1.1

titre

118.2

217.4

2.59

500

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.69

0.34

1.0

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

235

1.15

0.33

1.0

u/ml

10.3

20.4

2.00

193

(3011897) Casein IgE Ab [Units/volume] in Serum

119

725

1.08

0.33

1.3

u/ml

1.7

8.8

1.53

173

(3020874) Milk IgE Ab [Units/volume] in Serum

379

2591

0.96

0.31

1.1

u/ml

2.3

3.0

0.29

129

815

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2179

14099

1.02

0.31

1.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

441

2796

1.04

0.30

1.8

1.4

g/l

0.9

0.77

435

2777

(3025886) Oxalate [Mass/time] in 24 hour Urine

102

1.22

0.30

1.2

—

(42870560) Thyrotropin [Units/volume] in Cord blood

393

1.10

0.30

1.0

mu/l

9.9

8.5

0.94

332

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

258

1.12

0.27

1.0

u/ml

0.7

1.4

0.56

195

(3007542) Rye IgE Ab [Units/volume] in Serum

202

1.14

0.27

1.1

1.0

u/ml

0.7

9.5

0.48

(3029612) Listeria sp Ab [Titer] in Serum

1.24

0.26

1.2

1.4

—

(40758358) Immune stain study

141

1.17

0.26

1.0

—

(4038314)

315

0.90

0.26

1.1

1.2

—

(3022475) Manganese [Moles/volume] in Blood

225

0.88

0.25

1.2

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

111

1.18

0.24

1.1

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

151

1046

0.95

0.24

2.8

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

151

1045

0.95

0.23

5.5

6.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

640

0.93

0.23

1.8

ug/l

2.5

3.5

0.49

389

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.23

0.23

1.0

u/ml

0.1

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

1.24

0.23

1.2

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

1.31

0.23

1.2

1.6

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

1.26

0.23

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

332

2254

0.97

0.22

1.1

1.0

u/ml

0.8

0.7

0.07

332

(3001556) Androgen free Index in Serum or Plasma

427

1.08

0.22

1.5

1.2

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.20

0.22

1.0

u/ml

0.1

0.2

—

(1002224) Polysomnography panel

2355

15308

1.01

0.21

1.1

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

114

791

0.95

0.21

2.0

1.9

—

(3003157) Bacteria [#/volume] in Mother's milk

0.81

0.19

5.6

6.7

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.20

0.19

2.2

2.4

mu/l

2.7

2.3

0.12

(40759632) Porphyrins [Mass/mass] in Stool

1.21

0.18

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

393

1.07

0.18

1.1

1.0

u/ml

0.3

0.5

0.49

213

(46235168) Fasting glucose [Moles/volume] in Blood

436

0.93

0.18

5.3

1.2

mmol/l

8.5

6.9

2.44

134

(3045683) HLA typing for celiac disease panel - Blood or Tissue

363

2326

1.03

0.17

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

273

1.08

0.17

1.1

u/ml

6.6

9.3

0.49

180

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

302

2040

0.97

0.17

1.4

1.3

—

(3018001) Oat IgE Ab [Units/volume] in Serum

279

0.92

0.17

1.1

1.0

u/ml

0.1

1.0

0.81

105

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.20

0.17

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

321

2055

1.03

0.17

5.9

6.7

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

135

0.88

0.16

1.0

u/ml

0.8

0.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

192

1.10

0.15

2.2

1.7

umol/l

0.8

0.7

0.69

148

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

306

2062

0.98

0.15

1.3

1.4

mmol/l

5.8

5.6

2.33

284

1954

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

160

0.90

0.13

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

725

4699

1.01

0.13

1.1

1.0

u/ml

0.3

0.5

0.88

224

990

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.85

0.13

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.17

0.12

1.1

1.0

umol/l

445.0

351.0

—

(3008898) HLA-B27 [Presence]

2001

13058

1.01

0.11

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

376

2515

0.98

0.11

1.1

u/ml

5.2

4.9

0.05

126

682

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

835

5549

0.99

0.11

1.1

u/ml

3.2

2.9

0.18

328

2765

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2705

17883

0.99

0.11

3.7

3.1

u/ml

61.0

48.0

1.00

2617

17267

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

117

0.90

0.10

1.0

u/ml

1.0

0.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

767

5096

0.99

0.10

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

193

1240

1.02

0.10

1.1

u/ml

2.8

16.2

1.00

121

730

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

184

0.93

0.10

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

840

5468

1.01

0.09

1.1

u/ml

4.3

5.5

1.19

412

2289

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

598

1.03

0.09

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.11

0.09

1.0

u/ml

0.1

0.8

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

256

1.05

0.08

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1326

8657

1.01

0.08

1.4

1.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

443

0.96

0.08

1.1

1.0

u/ml

9.0

1.5

0.42

238

(3002079) Sodium [Moles/time] in 24 hour Urine

1.02

0.08

1.1

mmol/24h

151.8

142.3

—

(3044336) Cobalt [Moles/volume] in Urine

0.89

0.07

2.5

2.4

nmol/l

10.3

28.6

2.21

(3020650) Glucose [Presence] in Urine

146

980

0.98

0.07

1.5

1.4

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

251

1.05

0.07

1.1

u/ml

2.9

2.4

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

127

0.93

0.06

1.0

u/ml

1.5

0.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

435

1.03

0.05

1.1

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

891

5827

1.01

0.05

1.1

u/ml

5.2

4.5

0.41

422

2310

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1706

11251

1.00

0.04

2.0

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

229

1521

0.99

0.04

1.2

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

222

1472

0.99

0.03

1.3

1.4

72.1

73.1

0.43

207

1404

(3017958) Strawberry IgE Ab [Units/volume] in Serum

119

1.05

0.02

1.0

u/ml

0.1

0.19

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

435

0.98

0.02

1.1

1.0

u/ml

1.6

0.5

0.38

235

(3016031) Almond IgE Ab [Units/volume] in Serum

296

0.98

0.02

1.0

1.1

u/ml

0.9

0.8

0.09

183

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

495

3267

1.00

0.02

4.3

4.7

u/ml

120.7

107.6

0.13

130

1029

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

218

1443

0.99

0.02

1.3

1.4

mu/l

584.3

679.8

0.43

203

1375

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.94

0.02

3.7

5.7

mmol/l

0.2

0.31

(43055514) Macroprolactin [Presence] in Serum or Plasma

165

1079

1.01

0.01

1.3

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.98

0.00

1.1

nmol/24h

68.9

103.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.97

0.00

1.5

1.0

2.6

2.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

185

0.99

0.00

1.0

u/ml

0.3

7.7

—

100

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

541

1.00

0.00

1.2

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

130

852

1.00

0.00

2.2

2.6

ng/l

114.3

108.7

0.16

467

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.00

0.00

2.0

2.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.92

0.00

1.0

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.96

0.00

1.3

1.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.91

0.00

1.0

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.84

0.00

1.0

1.1

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_INFLUPNEU and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_INFLUPNEU	3.184 [2.93, 3.47]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 104721 out of 278871 females with J10_INFLUPNEU died.

Males

Parameter	HR [95% CI]	p-value
J10_INFLUPNEU	3.736 [3.41, 4.09]	< 0.001
Birth year	0.976 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 123947 out of 312398 males with J10_INFLUPNEU died.

Mortality risk

Mortality risk for people of age

years, who have J10_INFLUPNEU.

N-year risk	Females	Males
1	0.146%	0.285%
5	0.923%	1.81%
10	2.341%	4.455%
15	4.229%	8.324%
20	7.082%	13.754%

Relationships between endpoints

↥

Index endpoint: J10_INFLUPNEU – Influenza and pneumonia

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Influenza and pneumonia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints